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SUMMARY
Cardiovascular disease (CVD), also known as heart disease, is the leading cause of
death globally. About eight million Americans are now suffering from CVD with 2,400
dying each day [1]. The gold standard for evaluating CVD, catheter coronary angiography,
is invasive and expensive [2]. An alternative technique, computed tomography angiography
(CTA), is less invasive, relatively inexpensive and faster [3, 4]. However, this emerging di-
agnostic tool suffers from limited temporal resolution resulting in cardiac motion artifacts.
To minimize the effect of cardiac motion, cardiac CTA data acquisition requires triggering
when cardiac motion is minimal within the cardiac cycle, known as the cardiac quiescence.
The overarching goal of this work is to improve the diagnostic quality and reduce the
radiation dose of cardiac CTA imaging by developing novel gating strategies that optimize
prospective gating. Prospective gating is a scan acquisition type of cardiac CTA that re-
sults in less radiation dose1 but requires triggering during the cardiac quiescence. Since
the inception of cardiac CTA, quiescence prediction has relied almost exclusively on the
real-time electrocardiography (ECG) signal [6, 7]. However, while providing important
information as to the electrical activity of cardiac motion, ECG-triggered gating fails to
inherently capture the mechanical movement of the heart and thus is suboptimal. Seis-
mocardiography (SCG) is a non-invasive strategy that measures the acceleration of chest
wall caused by cardiac motion. Therefore, SCG can be a potential supplement to ECG for
cardiac quiescence detection and prediction [8].
This work presents a multimodal gating framework that fuses quiescence predictions
derived from ECG and SCG. Cardiac quiescence derived from the B-mode echocardiog-
raphy signal was used as the baseline for comparing the performance of SCG and ECG.
Using a heart-sound-based waveform matching approach, the SCG-based quiescence pre-
1A high level of radiation exposure of 12 mSv using retrospective gating can possibly be reduced to only
about 4 mSv by prospective gating. Note that a 10 mSv CTA exam may relate to an increasing possibility of
fatal cancer of approximately 1 in 2,000 cases [5].
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diction demonstrated improved accuracy for cardiac gating. To fuse ECG and SCG pre-
dictions, an artificial neural network (ANN) was employed with cardiac features selected
from the ECG and SCG on a beat-by-beat basis. The fusion-based prediction yielded more
accurate and robust quiescence prediction compared with the traditional ECG-only-based
prediction. The diagnostic quality of reconstructed CTA images at predicted timings was
interpreted by a radiologist and the assessment indicated improvement with the inclusion of
SCG signals. Furthermore, a proof-of-concept prototype that implements the multimodal
framework in a near real-time manner via integration of existing hardware and software
was developed. Testing of this prototype using both the pre-recorded and real-time data
demonstrated the feasibility of the real-time multimodal framework.
It is expected that the next generation of cardiac imaging machines, including CTA and
magnetic resonance imaging (MRI), can be triggered more accurately in real-time by using




Cardiovascular disease (CVD), also known as heart disease, refers to conditions involving
narrowed or blocked blood vessels that can result in a heart attack [9]. According to the
World Health Organization, CVD is the leading cause of death globally. In 2015, approxi-
mately 17.7 million people died from CVD, comprising 31% of global death [10].
Currently, catheter coronary angiography (CCA) is the gold standard for assessing coro-
nary blood vessels to evaluate and manage CVD [11]. However, CCA is invasive in that
it requires an insertion of a catheter from the upper thigh which is then threaded through
the aorta into the heart. The intraarterial injection of contrast agent enables visualization of
the arterial blockage via x-ray imaging. An illustration of CCA is shown in Figure 1.1 (A).
CCA may lead to non-negligible complications such as bleeding, stroke and heart attack
[12], and is relatively expensive [13] with a mean hospital charge of $37, 000. Further-
more, while CCA visualizes the coronary arterial lumen, CCA does not directly provide
information about vessel wall abnormalities [11].
As an alternative, computed tomography angiography (CTA) [14] is a less invasive,
less expensive and faster technology than CCA [3, 4]. CTA utilizes x-rays in combination
with computerized analysis for imaging. CTA sends beams of x-rays from several different
angles of a rotating device through the area of interest in the patient’s body. The obtained
slices of projection images are then assembled by a computer to reconstruct into a three-
dimensional volume for diagnoses. An illustration of CTA is shown in Figure 1.1 (B).
The value of cardiac CTA is in ruling out people at low to intermediate risk of CVD. It
has been shown in many studies that cardiac CTA has very high negative predictive value1
1Negative predictive value is the probability that subjects with a negative screening test truly do not have
the disease. Positive predictive value is the probability that subjects with a positive screening test truly have
the disease.
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Figure 1.1: Comparison between CCA and CTA. (A) CCA is invasive in that it requires
an insertion of a catheter from the upper thigh which then threads through the aorta into
the heart. The intraarterial injection of contrast agent enables visualization of the arterial
blockage via x-ray imaging. (B) CTA utilizes x-rays in combination with computerized
analysis for imaging. Beams of x-rays are sent from several different angles of a rotating
device through the area of interest in the patient’s body. CTA is a less invasive technique
compared with CCA. Figure (B) reproduced from [15].
up from 93% to 100% [16]. On the other hand, the low diagnostic yield (low positive
predictive value) of CCA raises the concern of undergoing unnecessary invasive tests for
people at low to intermediate risk of CVD. Approximately 40% of the CCA examinations
reveal no coronary artery disease [17]. It is important to mention that cardiac CTA and
CCA can possibly achieve the same level of diagnostic quality. Therefore, cardiac CTA
may be a more suitable diagnostic technique for the low-risk group of individuals.
Yet, cardiac CTA is limited by temporal resolution. In the context of cardiac imaging,
high temporal resolution is achieved when imaging is conducted fast enough to “suspend”
the motion of the heart. Otherwise, the reconstructed images could be blurred or mis-
aligned due to cardiac motion. Cardiac motion artifact is one of the important factors that
compromises image quality which directly affects diagnoses. Therefore, to improve the
diagnostic quality of cardiac CTA, it is crucial to obtain cardiac CTA images during a time
interval when the heart is in the state of minimal motion, or within the quiescent period of
the cardiac cycle.
A primary factor that affects the diagnostic quality and radiation dose of the cardiac
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CTA is the scan acquisition type. The two main scan acquisition types are retrospective
gating and prospective triggering2. Gating is a general term describing the action of a car-
diac CTA machine sending x-rays to start acquiring imaging data. Triggering is a special
case of gating which requires a timed triggering signal to activate the action of data acqui-
sition. In retrospective gating, x-rays are sent throughout the whole cardiac cycles for a
continuous data acquisition until the heart volume is covered. Afterwards, retrospectively,
only part of the selected data that yield high image quality are reconstructed. Alternatively,
for prospective triggering, x-rays are triggered to be sent only during quiescent periods. In
this case, a limited radiation dose occurs within each cardiac cycle. Prospective triggering
is also called the step and shoot scan acquisition method. Currently, cardiac gating of clin-
ical CTA machine relies almost exclusively on the ECG signal. An illustration of the two
scan acquisition types are presented in Figure 1.2.
Figure 1.2: (A) Retrospective ECG gating and (B) prospective ECG triggering. Purple area
is the period during which the patient’s body is exposed to radiation. R denotes the R-peak
of ECG signal. Figure reproduced from [18].
With prospective cardiac CTA, the radiation exposure of 12 mSv associated with the
128-slice retrospective cardiac CTA can possibly be reduced to only approximately 4 mSv
[5, 19]. Figure 1.3 summarizes the mean effective dose associated with the two scan ac-
quisition types. The radiation dose is especially important for individuals with congenital
heart disease as they have to go through many cardiac CTA scans throughout their lives.
Therefore, imaging using prospective triggering for cardiac CTA data acquisition is vital
2Prospective triggering is a rigorous term. A more general term used interchangeably in some publications
is prospective gating.
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for the health of individuals.
Figure 1.3: Mean effective dose associated with retrospective (12 mSv) gating and prospec-
tive triggering (4 mSv). Statistics are based on the Siemens Definition Flash dual-source
128-slice CTA scanner (Siemens, Erlangen, Germany). Horizontal line in each box shows
median and top and bottom lines of boxes show interquartile range. Figure reproduced
from [18].
1.1 Research Statement
For prospective triggering, the CTA machine is only triggered to acquire data during pre-
dicted cardiac quiescence whose occurrence is determined prior to data acquisition. Car-
diac quiescence is a state of minimal motion relative to the overall motion within a cardiac
cycle. The predicted quiescence is often in the form of a time delay from a particular fea-
ture (e.g., the most recent R-peak of ECG) in the cardiac signal. Accordingly, accurately
predicting cardiac quiescence is crucial for obtaining cardiac CTA data that yield high di-
agnostic quality. The focus of this research investigates the cardiac-motion-based signal,
seismocardiography (SCG), as a supplemental gating signal, that can potentially provide




To achieve the goal of optimizing quiescence prediction for prospective triggering, a mul-
timodal gating strategy encompassing a cardiac-motion-based signal was developed. Cur-
rently, clinical quiescence prediction relies almost exclusively on the real-time ECG signal.
This is not always reliable since ECG is only a proxy of the heart motion and has been
demonstrated to be an imprecise marker of the instantaneous cardiac mechanical motion
[20, 21]. As an alternative, SCG [22, 23] directly measures the mechanical state of the
heart vibration and has the potential in improving quiescence prediction [8, 24, 25].
To date, cardiac CTA is yet to be the mainstream diagnostic tool for examining individ-
uals with suspected CVD due to lack of reliability in achieving enhanced diagnostic quality
with low radiation dose in widespread clinical practice. The ultimate goal of this work is
to apply a multimodal gating framework to cardiac CTA scanner. To achieve this goal, a
proof-of-concept near real-time prototype was developed and tested.
In summary, the major contributions of this work include:
1. Design of a waveform matching quiescence prediction algorithm that utilizes per-
sonalized heart sound waveforms of SCG signal. Using quiescence derived from the
B-mode echocardiography as the baseline, SCG-based prediction was more accurate
as compared to ECG-based prediction on a beat-by-beat basis3. This demonstrated
the potential of SCG as a supplemental gating signal to ECG to achieve more accurate
quiescence predictions.
2. Development of an ECG-SCG-based multimodal framework that fuses predictions
from ECG and SCG using an artificial neural network (ANN). Cardiac features ex-
tracted from ECG and SCG signals enable the ANN to generate weights correspond-
ing to predictions from ECG and SCG. Combining information from electrical and
3Ideally, quiescent periods exist in every cardiac cycle, and within each quiescent period cardiac imaging
data can be acquired with the best diagnostic quality. Thus, the quiescence prediction can be made for each
cardiac cycle.
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mechanical signals compensates for the sub-optimal prediction from ECG as well as
for the susceptibility of SCG signal to noise and artifacts. Fusion-based quiescence
prediction advanced ECG-only- and SCG-only-based methods because its predic-
tions were more accurate and robust4.
3. Assessment of the diagnostic quality of the coronary vessels based on CTA images
reconstructed at predicted quiescence from ECG-, SCG- and fusion-based methods.
The radiological interpretation in visualization of calcification and motion artifacts
quantitatively validated the value of incorporating the cardiac-motion-based signal
for quiescence prediction.
4. Integration of hardware and software platforms to serve as a proof-of-concept proto-
type of a near real-time multimodal framework for triggering CTA data acquisition.
Testing results demonstrated the feasibility of the real-time fusion-based quiescence
prediction framework.
4In the case of quiescence prediction for cardiac gating, robustness refers to the ability to resist heart rate
variability and heart rate prediction error caused by inter- and intra-personal differences. Quantitatively, it




To develop gating strategies for triggering cardiac CTA data acquisition, it is necessary to
understand the related cardiac sensing modalities. Additionally, it is also important to grasp
some basic knowledge of cardiovascular physiology.
2.1 Cardiac Sensing Modalities
This work investigated three sensing modalities, electrocardiography (ECG), seismocar-
diography (SCG) and B-mode echocardiography. Visualization of these signals, including
the B-mode echocardiography, echocardiography deviation, ECG and SCG signals are dis-
played in Figure 2.1. The echocardiography deviation is a magnitude of velocity derived
from the B-mode echocardiography, and in the case of Figure 2.1 is applied to the inter-
ventricular septum. The cardiac quiescence detected from the echocardiography deviation
signal is used as the baseline while comparing the performance of ECG and SCG.


















































Figure 2.1: Echocardiography: B-mode echocardiography frame from an apical four cham-
ber view of the heart, with contour shown around the inter-ventricular septum (IVS); Echo
Deviation: Motion signals derived from B-mode sequences by applying the phase-to-phase
deviation measure elaborated in [26]; ECG: Time-series de-noised ECG signal; SCG:
Time-series de-noised SCG signal.
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2.1.1 Electrocardiography
Pioneered in the early 1900s, ECG is a traditional yet still a predominant technique for diag-
nosing cardiac-related conditions. ECG records the electrical activity of the heart through
electrodes placed on the skin [27]. Identifiable features in an ECG signal are shown in
Figure 2.2. In an ECG waveform, a pair of adjacent R-peaks is an indication of one cardiac






















Figure 2.2: Waveform of ECG. ECG nomenclatures: ventricular depolarization (QRS com-
plex) and repolarization (T wave).
Since the inception of prospective cardiac CTA, quiescence prediction has relied almost
exclusively on the real-time ECG signal. A pre-defined linear piece-wise function F pre-
dicting the quiescent phase with respect to heart rate is often employed [28, 29]. Given
a predicted heart rate (HR) r̂, the gating function F maps r̂ to a one-on-one predicted
quiescent phase P and
P = F(r̂) (2.1)
Cardiac phase (%) is a percentage interval of a cardiac cycle normalized for heart rate
variability. Quiescent phase is a cardiac phase that lies within a quiescent period of a
cardiac cycle. Figure 2.3 displays five different ECG gating functions [28–32] that are
summarized in multiple works on different cardiac CTA scanners. The different versions of
gating functions suggests that ECG-based gating lacks standardization, which leaves room
for improvement. In addition, such function-based gating approach neglects the intra- and
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inter-personal variation in cardiac signals with respect to the cardiac motion and thus is not
always reliable. Furthermore, while providing important information as to the electrical
activity during the cardiac cycle, ECG gating fails to inherently capture the mechanical
motion of the heart.










ECG Gating Function: Example 1
Start
Center










ECG Gating Function: Example 2
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ECG Gating Function: Example 3
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ECG Gating Function: Example 4
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ECG Gating Function: Example 5
Start
Center
Figure 2.3: ECG gating functions. Examples 1-5 are summarized from [28–32], respec-
tively. Center represents that gating information is the center of the quiescent period, and
start represents that gating information is the start of the quiescence period. Depending on
the requirement of different CTA scanners, the gating information may vary.
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Depending on the CTA scanner, the predicted phase for gating is either the center or
start of the data acquisition window. This research used a Siemens SOMATOM Definition
dual-source 64-slice CTA scanner (Siemens, Erlangen, Germany). The temporal resolu-
tion of this scanner remains at 83 ms at all heart rates. In other words, the length of the
reconstruction window is a constant Tacq = 83 ms [33]. The configuration of this scanner
requires a predicted phase to indicate the middle of data acquisition widow. Therefore, in
the computerized processing of this work, the phase of minimal motion was identified and
designated as the midpoint of the cardiac CTA data acquisition window. The relationship
between the center and start phase of the data acquisition window at a predicted HR r̂







where Pcenter and Pstart are cardiac phases (%) denoting the center and start of the quies-
cence, respectively.
2.1.2 Echocardiography
Echocardiography utilizes the transmission and reception of ultrasound to directly evaluate
cardiac motion in real-time. Important echocardiographic techniques for assessing cardiac
dynamics include M-mode, B-mode, Doppler and speckle tracking. B-mode echocardiog-
raphy [34] is a two-dimensional presentation that results from modulating the brightness of
the spot in the echo-producing interface. The four chambers of the heart can be visualized
from the B-mode echocardiography.
In early works, echocardiography was demonstrated to provide accurate gating tim-
ing [20, 35] for cardiac CTA. The intersection that separates the left and right ventricular
chambers is the inter-ventricular septum (IVS). An echocardiographic visualization of the
four-chamber apical view and the IVS are shown in Figure 2.4. The motion of IVS can be
recorded in echocardiography and IVS has been shown as a reliable predictor for coronary
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vessel quiescence [36]. Therefore, quiescence derived from the B-mode echocardiography
is considered as an excellent tool for assessing cardiac conditions in real-time [35] and can
be used as a baseline for quiescence.
Figure 2.4: Echocardiographic visualization of the four-chamber apical view. RV: right
ventricle; LV: left ventricle; RA: right atrium; LA: left atrium; IVS: inter-ventricular sep-
tum. Figure reproduced from [37].
Applying a frame-to-frame deviation measure developed by a previous research [26],
the magnitude of the IVS velocity was derived from B-mode sequences. This converts
the two-dimensional cardiac information from the B-mode echocardiography into a unidi-
mensional signal. Quiescence can be identified from this derived velocity magnitude and
modeled as a linear function of heart rate [38]. In this work, quiescence derived using
the modeled linear function was considered as the baseline when comparing quiescence
derived from ECG and SCG.
Despite the merits of echocardiography in quiescence prediction, it has some disadvan-
tages, including operator-dependence and incompatibility with CTA since clinically avail-
able transducers can cause artifacts in the CTA images [8], making it impractical for the
real-time CTA data acquisition.
2.1.3 Seismocardiography
Seismocardiography (SCG) is a noninvasive strategy that records the low-frequency vibra-
tion due to heart motion by placing an accelerometer on the chest wall [39]. An example
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of SCG waveform along with its identifiable features are displayed in Figure 2.5. Different





















Figure 2.5: Waveforms of ECG and SCG. SCG nomenclatures: isovolumic movement
(IM), aortic valve opening (AO), mitral valve opening (MO), and rapid filling (RF).
The effectiveness of SCG in facilitating diagnosis for cardiac disease have been demon-
strated by multiple studies. Early research compared the diagnostic accuracy of ECG
with SCG and suggested that SCG can significantly improve the accuracy for detection
of anatomic and physiologic coronary artery disease (CAD) [40]. It was also reported that
SCG simultaneous with ECG is helpful in detecting cardiac abnormalities such as prema-
ture ventricular contraction. With respect to at-home monitoring and remote CVDs follow-
up systems, SCG-based measurement modalities were emphasized due to its robustness,
feasibility and capability in detecting cardiac vibrations [41].
SCG bears superior promise as a cardiac gating signal due to its operator-independence
as compared to echocardiography. The SCG accelerometer possesses a smaller footprint
than the echocardiography transducer, thus significantly minimizes streak artifacts [8]. Fur-
thermore, the inclusion of SCG in cardiac CTA gating guards against missing ECG signals
when a pacemaker is used to electrically pace the cardiac cycle.
With respect to SCG as a gating signal, a recent study evaluated the potential of tri-axis
SCG as a gating signal for positron emission tomography (PET) [42]. The same research
group presented a dual-sensor quiescence detection and prediction method relying on a
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tri-axial chest accelerometer and gyroscope for PET [43], reporting an improvement in di-
agnostic accuracy on both reconstructed phantom images and two patients with atheroscle-
rotic disease.
The quiescence predicted using SCG signal can possibly achieve the same level of
accuracy as the baseline echocardiography. An early research evaluated the relationship
between SCG and echocardiography and reported consistency between the timing of phases
of these two modalities, indicating the similar accuracy in measuring cardiac time intervals
[23]. Further comparison between SCG and echocardiography [22–25] suggested that SCG
can reliably capture cardiac motion and therefore potentially be a supplement to ECG in
CTA gating.
The current advances in SCG signal processing include but are not limited to, the iden-
tification of quiescent heart phases [44, 45], extraction of respiratory and cardiac gating
information [42], and delineation of the SCG signal [46, 47]. Multiple signal processing
techniques including frequency analysis, time series regression [48] and wavelet transform
[49] have been applied to ECG signals for cardiac research, but the exploration of SCG-
based prediction is still at an initial stage.
2.2 Cardiovascular Physiology Basics
While there are multiple approaches to mitigate the effects of cardiac motion on cardiac
CTA such as using advanced cardiac CTA reconstruction algorithms [50] or lowering the
heart rate pharmacologically with β-blocker medication [51], the most straightforward ap-
proach is to avoid it altogether. In other words, acquiring data during quiescent periods.
The quiescent period exists in two portions, systole and diastole, of a cardiac cycle, as
illustrated in Figure 2.6. Systole and diastole make up one cardiac cycle wherein the heart
contracts to pump blood out during systole and dilates to relax during diastole [52]. Systolic
quiescence occurs during the ventricular reduced ejection period and diastolic quiescence
occurs during the reduced ventricular filling period [53], or more accurately diastasis. Di-
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astasis occurs in the middle 1/3 of diastole. The duration of systolic and diastolic quiescent
periods vary with the heart rate.
Figure 2.6: ECG and SCG traces. One cardiac cycle can be divided into systole and di-
astole. The heart contracts to pump blood out during systole and dilates to relax during
diastole. Diastasis is the middle stage of diastole and is typically when quiescent period
takes place. The systolic and diastolic quiescent periods are highlighted in blue. In SCG
signal, the two high frequency accelerometric components, HS1 and HS2, are associated
with the first and second heart sounds, respectively.
Heart sounds are discrete bursts of acoustic vibrations that vary in intensity, frequency,
quality and duration [54]. The first heart sound is caused by the closure of atrio-ventricular
valves; the second heart sound is from the closure of semilunar valves [55]. Phonocar-
diogram (PCG) is the graphical representation of a heart sound recording. As a standard
nomenclature, the first and second heart sound denote as S1 and S2 in phonocardiogram
(PCG) [56, 57]. S1 leads the onset of systolic quiescent period while S2 occurs after the
systolic quiescent period and precedes the diastolic quiescent period. By placing an ac-
celerometer on the sternum, the first and second heart sound associated waveforms can be
detected [55] by the SCG. Different from PCG, SCG presents relative low frequencies of
body vibrations. This research focuses on the high frequency accelerometric component
of SCG which is associated with cardiac sounds. To refer to the same cardiac event but
differentiate the sensing modalities, PCG and SCG, HS1 and HS2 are used in represent-
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ing SCG as the source signal in this work. In addition, the term “heart sound associated
waveform” refers to the high frequency accelerometric component in SCG. Table 2.1 sum-
marizes characteristics of the first and second heart sound. These characteristics set criteria
for identifying the heart sound associated waveforms in SCG to be discussed in Chapter 4.





Duration Longer (∼ 0.14 s) Shorter (∼ 0.11 s)
Time intervals of cardiac events and relationship between events set a baseline for com-
puterized processing for detecting and predicting quiescence. The QRS complex is the
most visually obvious part of the ECG signal. It indicates the depolarization of the ventri-
cles. The duration of the QRS complex is 0.06 to 0.10 second for adults. The first heart
sound overlaps with the R-peak of ECG.
Yet, many relationships among cardiac features cannot be consolidated into a universal
pattern that applies to everyone. The identification of cardiac features becomes challenging
without a quantified pattern. For example, the T wave in an ECG represents the ventricular
repolarization and occurs at the end of systole. The T wave is often observed to coincide
with the 2nd heart sound associated waveform in SCG. However, the T wave is in fact
labile and does not have a bounded relationship with mechanical events such as the 2nd
heart sound. Another example is the variable duration of systole and diastole. For a healthy
subject with a steady heart rate, e.g. 75 bpm, systole normally lasts about 1/3 and diastole
2/3 of a cardiac cycle [58, 59]. However, this ratio varies with heart rate [60]. Typically,
the higher the heart rate, the shorter the percent of diastolic time compared to the entire
duration of the cardiac cycle. However, cardiac features from cardiac patients fail to follow
these rules most of the time.
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In such cases, empirical conclusions are followed. It was found in [31] that end-systolic
CTA reconstruction yielded sharper images for high heart rate individuals and end-diastolic
reconstruction for low heart rate individuals. This indicates that for individuals with lower
heart rate, for example average heart rate below 80 bpm, prospective triggering of data ac-
quisition at diastolic quiescence is more suitable because diastolic reconstructions is more
likely to achieve superior image quality as compare to systolic reconstruction [29]. As
heart rate increases, the duration of cardiac cycle decreases.
2.3 Cardiac Gating
In 2004, a method and apparatus of cardiac CTA imaging using ECG and mechanical mo-
tion signals was proposed in [61, 62] but not yet validated nor implemented. In addition,
this proposed method of comparing and correlating the ECG and mechanical motion sig-
nal is designed to determine the phases of cardiac region which serves for retrospective
gating. In recent years, the idea of dual gating has been investigated for cardiac magnetic
resonance imaging (MRI) [63] and positron emission tomography (PET) in existing works
[42, 43]. This current research dates back to a proposed method and system that employs
ultrasound gating during the CT scans [64]. However, this method is not feasible during
the CTA exam due to the technician-dependent property of the ultrasound data acquisition.
As a step forward, the current research investigates the SCG signal as a viable potential.
Figure 2.7: ECG-based (A) and SCG-based (B) quiescence prediction. Areas covered in
grey contain succeeding unknown cardiac cycles. HS1 and HS2 are the 1st and 2nd heart
sound associated waveforms of SCG; ∆Tecg and ∆Tscg are predicted time durations.
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Figure 2.7 demonstrates the conventional ECG- (A) and the SCG-based (B) prediction
investigated in this work. HS1 and HS2 are heart sound associated waveforms of SCG
in systole and diastole, respectively [54, 55]. The vertical dotted line is the quiescence
derived from echocardiography which is considered as the baseline for quiescence in this
study. Areas covered in grey contain succeeding unknown cardiac cycles. The predicted
quiescence, measured as a time duration ∆T , is in reference to a cardiac feature within
the upcoming cardiac cycle. As a demonstration, only quiescence prediction in diastole is
reviewed here. Predicting ∆Tscg from HS2 involves less uncertainty than that from ∆Tecg
using R-peak of ECG as HS2 is more proximal to the quiescence, therefore this SCG-based
prediction method can potentially predict quiescence more accurately.
In this work, the SCG-based prediction was developed from a waveform template
matching approach in combination with a constructed delay function. Overall, SCG-based
prediction was more accurate than ECG-based prediction using quiescence derived from
echocardiography. To optimize the prediction accuracy on a beat-by-beat basis, a fusion-
based ECG-SCG prediction relying upon an artificial neural network (ANN) was further
developed. The fusion-based method quantitatively evaluates the signal quality based on
features such as the power spectral density and wavelet decomposition coefficients ex-
tracted from ECG and SCG signals as the input to the ANN.
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CHAPTER 3
PROTOCOL AND DATA ACQUISITION
This chapter lays an experimental foundation for the algorithm development and validations
to be discussed in the following chapters 4 and 5. In addition, this chapter reviews the pre-
processing procedures for raw signals of ECG and SCG.
3.1 Human Subject Protocol
Cardiac signals including ECG, SCG and echocardiography were acquired from seven
healthy subjects (mean age: 31; age range: 22-48; female/male: 3/4) and eleven cardiac
patients1 (mean age: 56; age range: 31-78; female/male: 5/6). Written, informed consent
was obtained from each participant and the study was conducted under the approval of the
Emory University Institutional Review Board.
3.2 Custom Data Acquisition System
This work used two sets of trimodal data acquisition systems. This section introduces the
custom data acquisition system which was developed by earlier work [8]. Chapter 6 will
elucidate an enhanced system. Simulations presented in Chapter 4 and Chapter 5 were
generated using data acquired from the old data acquisition system.
The custom data acquisition system consists of an in-house designed ECG-SCG device
and a commercial ultrasound machine Sonix RP Scanner (BK Ultrasound, Richmond, BC,
Canada) [8]. Figure 3.1 illustrates the data acquisition setup.
During data acquisition, each participant was resting in a supine position for approx-
imately 30 minutes, with the single-axis linear accelerometer placed against the sternum
1Cardiac patients studied in this work have structural or valvular heart diseases. The rationale for includ-
ing these patients was to enlarge the testing population since we scan several of these patients prior to various
interventions.
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Figure 3.1: Custom data acquisition system setup.
recording dorso-ventral vibrations transmitted to the chest wall. Figure 3.2 shows the
time line of data acquisition. It is worth mentioning that the participants were asked to
be as motionless as possible during the recordings. However, the beginning and end of
the recordings were typically heavily contaminated by motion artifacts while starting and
terminating the recording, and thus approximately 7% of the noisy recordings were not
included for analysis. After approximately 20 minutes of data acquisition using solely the
ECG-SCG custom device, at least six sessions of B-mode echocardiography data was ac-
quired simultaneously with the ECG-SCG recording from the custom device. Each session
of echocardiography was independent and ran for 10 seconds. Afterwards, the echocardio-
graphy data was synchronized with signals acquired from the custom device by matching
the ECG signals from both devices.
Figure 3.2: Data acquisition timeline.
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The ECG-SCG custom device acquired ECG and SCG signals at the rate of 1.2 kHz.
Both signals were pre-filtered and amplified by the analog end before feeding to a 16 bit
analog-to-digital converter (ADC). The single-axis accelerometer (ADXL327, Analog De-
vices, Inc., Norwood, MA, USA) weighs approximately 5 g and and has an RMS noise
of 250 µg/
√
Hz. The accelerometer was tuned to have a passband of 50 Hz [8]. While
many studies used the tri-axis accelerometer to measure the mechanical movement of the
heart, the tri-axis SCG signals have not yet been quantified with a widely acknowledged
standardization in terms of cardiac events, particularly with the heart sound in the lateral-
medial and superior-inferior directions for this study. A potential reason for this is the
intersubject variability observed in the tri-axis SCG signals [65, 66]. B-mode echocardio-
graphy data, specifically apical four-chamber view, were obtained at a rate of 50 Hz and
the associated ECG was recorded at 200 Hz. The redundant ECG signals from the two ma-
chines were used to align SCG and echocardiography signals, as well as to segment cardiac
beats.
Retrospective cardiac CTA data were acquired and reconstructed independently using
a Siemens SOMATOM Definition dual-source 64-slice CT scanner (Siemens, Erlangen,
Germany) with data acquisition window length of 83 ms. This CTA data will be used for
assessing the diagnostic quality of quiescence predicted from different modalities. The
work discussed in Chapter 4 and 5 used Siemens SOMATOM Definition as the CTA data
acquisition machine. In Chapter 6, a more advanced scanner, Siemens Force dual-source
192-slice CT scanner (Siemens, Erlangen, Germany), is introduced. The Siemens Force is
the most up-to-date cardiac scanner which is able to complete data acquisition within one
cardiac cycle. The temporal resolution of the Siemens Force is 66 ms. The work discussed
in Chapter 6 relates to Siemens Force scanner.
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3.3 Signal Pre-Processing
Raw signals were pre-processed to remove the noise and baseline drift [67]. Figure 3.3
illustrates the procedures of pre-processing. By analyzing the frequency spectrum, the
ECG signal and SCG signal were conditioned by a 256th-order FIR low-pass filter with a
Hamming window configuration and cutoff frequency 50 Hz [68]. For the ECG signal, this
was to ensure retention of the QRS complex of the ECG whose frequency range is 10-50
Hz [69]. For the SCG signal, this was to retain the high frequency components related to
heart sounds that are within 10 - 50 Hz [70]. Following the low-pass filter, was a notch
filter centered at 0 Hz with a cutoff of 1 Hz to remove the DC component and remaining
respiratory baseline drift in ECG and SCG signals [8, 71].
Figure 3.3: Pre-processing flowchart. fc is the cut-off frequency of the filters.
Figure 3.4 displays the ECG and SCG signals before and after pre-processing. The
spectrograms visually demonstrate the spectrum of frequencies over time for the signals
before and after pre-processing. The high-frequency noise and baseline drift have been
effectively removed.
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Figure 3.4: ECG and SCG signals (A) before and (B) after pre-processing. The spec-
trograms of SCG signals (C) before and (D) after pre-processing indicate that the high
frequency noise and low-frequency baseline drift have been filtered.
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CHAPTER 4
SEISMOCARDIOGRAPHY (SCG) - BASED QUIESCENCE PREDICTION
As an intermediate stage towards optimizing real-time cardiac CTA gating, investigation
was first made on the cardiac-motion-based quiescence detection and prediction. SCG as a
motion-based signal captures the mechanical movement of the heart and has the potential
to more accurately predict cardiac quiescence than the ECG-only-based prediction [40], as
introduced in Chapter 2. Thus, this part of the work focuses on SCG-based detection and
prediction.
Among various identifiable features in the SCG signal such as aortic valve opening
(AO) and rapid ejection (RE), the high frequency components associated with the first and
second heart sounds [55, 70] were selected as the cardiac features of interest. Figure 4.1
illustrates the two detected heart sound associated waveforms, HS1 and HS2, in a synthe-
sized SCG signal. The synthesized signal highlights the selected heart sound associated
components by completely filtering out other components of the signal. The heart sound
associated components are morphologically embodied as waveforms with high frequency.



















HS1 HS2 HS1 HS2
Figure 4.1: Traces of de-noised ECG and synthesized SCG signals. The heart sound asso-
ciated waveforms HS1 and HS2 are presented in the synthesized signal as waveforms with
high frequency and intensity. The systolic and diastolic quiescent periods are highlighted
in blue.
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The rationale for selecting the heart sound associated cardiac feature is twofold. Single
features are instantaneous and variable, while the selected accelerometric components last
for a relative longer duration and indeed encompass multiple cardiac features, making the
accelerometric waveforms easier to identify. In addition, the heart sound associated ac-
celerometric component occurs after the onset of the R-peak of ECG. As a more proximal
reference to the quiescence, the heart sound associated component thereby can potentially
predict the cardiac quiescence more accurately. Correspondingly, HS1 can be the reference
for predicting systolic quiescence and HS2 for predicting diastolic quiescence. The tem-
poral localization of HS1, HS2 and the corresponding quiescent periods are presented in
Figure 4.1.
However, capturing the heart sound associated waveform in SCG faces challenges. Tra-
ditionally, a waveform nomenclature-based approach to identifying cardiac features is not
robust. The SCG markers are inconsistent if solely following the template indices [42, 72].
Additionally, there is no universal identification template that works for signals of all in-
dividuals. The automatic annotation approach for SCG proposed in [73] shows accurate
identification, but only for healthy subjects. Therefore, identifying features based on a
designated template can be nontrivial and complicated.
This work developed a template matching approach to detect the heart sound associ-
ated waveforms. In summary, the template matching approach employs the similarity in
morphology across heart beats by generating an ensemble template to correlate with the
streaming SCG signal, thereby, the occurrence and timing of the desired waveforms are
detected.
The heart sound associated waveform advances the corresponding quiescence by a du-
ration of time, or time delay, to be predicted. This time delay can be derived from a
pre-generated function, i.e., a phase delay function with respect to the heart rate, using
accelerometric and echocardiographic information. Since both the waveform template and
delay function are constructed out of the personalized cardiac signals, the inter-personal
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variation issue in the ECG-only-based prediction is diminished. To be able to extract per-
sonalized cardiac information, a 2-3 minute pre-test is required before the actual cardiac
CTA exam.
To present the SCG-based quiescence prediction in a strategic manner, a schematic
diagram in Figure 4.2 shows major components for prediction. The SCG-based prediction
consists of two sequential epochs, the pre-test epoch and offline prediction epoch. The 3
minute pre-test enables construction of the personalized phase delay function (Section 4.3)
and waveform template (Section 4.2), which then facilitates quiescence prediction on pre-
recorded cardiac signals (Section 4.6) in the offline prediction epoch. Each component for
prediction is elaborated individually in the following sections. The offline prediction lays
a foundation for developing a real-time prediction strategy. The real-time implementation
is presented in Chapter 6.
Figure 4.2: Schematic diagram of the SCG-based prediction. The SCG-based prediction
consists of two sequential epochs, the pre-test epoch and offline prediction epoch. The 3
minute pre-test enables construction of the personalized phase delay function (Section 4.3)
and waveform template (Section 4.2), which then facilitates quiescence prediction on pre-
recorded cardiac signals (Section 4.6) in the offline prediction epoch. Major components
are elaborated individually in the following sections.
The quiescence predictions were made on a beat-by-beat basis. To evaluate the predic-
tion performance, the prediction errors were retrospectively obtained by comparing against
the baseline quiescence derived from the personalized echocardiography. The prediction
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errors of ECG-only- and SCG-only-based methods were then compared as a primary mea-
sure of prediction performance. Other measures include variation of prediction errors with
respect to the heart rate variability and to the heart rate prediction errors.
4.1 B-mode Echocardiography Baseline
The cardiac quiescence derived from the B-mode echocardiography was used as the base-
line for comparing the prediction performance of ECG- and SCG-based methods. It was
reported that the approximated magnitude of velocity of the coronary vessels can be de-
rived by estimating the motion of the interventricular septum (IVS) [36]. An earlier work
developed a method to quantify the motion of IVS from the echocardiographic B-mode se-
quences by applying the phase-to-phase deviation measure [26]. As a result, the motion of
IVS can be presented as a uni-dimensional motion signal from which systolic and diastolic
quiescences can be derived, as presented in Figure 4.3.
Figure 4.3: Estimated echocardiographic motion signal derived from the movement of IVS
using the phase-to-phase deviation measure [26]. The voting mechanism was applied to
identify robust quiescences. Two groups of candidate quiescence in systole, one in gold
circle marker and the other in red solid marker, are shown as an example.
As mentioned earlier, the R-R intervals of the synchronized ECG were used to segment
the uni-dimensional cardiac signals and were used to define the cardiac phases (%). Sys-
tolic and diastolic quiescent phases are characterized as phases with the least velocity in
the systolic (typically with center before 60% of a cardiac cycle) and diastolic (typically
with center after 60% of a cardiac cycle) periods of a cardiac cycle, respectively.
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To generalize the relationship between the derived quiescence from echocardiography
and the heart rate based on the acquired echocardiography data1, a linear model was em-
ployed. A linear model is by nature straightforward and easy to implement. Previously,
a linear relationship was observed between the quiescent phases (%) derived from both
the SCG as well as the echocardiography with respect to the heart rate, respectively [44].
Therefore, relying on the assumption that there exists a linear relationship between a car-
diac event, i.e. cardiac quiescence (in percentage phase), and the heart rate (bpm), this
work condensed the cardiac signal information into pairs of slope and intercept.
However, to obtain an optimal linear model is not straightforward. The traditional
approach to identifying the lowest point, or the quiescence, within a certain searching range
is not robust enough to identify the same feature, because there could be more than one
potential minima that meet the requirement of being a quiescence. Therefore, a voting
mechanism was designed to generate a linear model with the least fitting error.
The voting process involves two epochs. The first epoch selects two candidates, both
from systole or from diastole, as cardiac quiescences. These quiescences from multiple
cardiac cycles form two groups of candidates. In the second epoch, the total least square
residuals obtained by forming a linear fit of the quiescences with respect to the heart rate
from the two groups were compared. The group with less residual was considered as an
optimal linear model to generalize for the relationship between cardiac quiescence and the
heart rate. Figure 4.3 marks the two groups of candidate quiescence. Figure 4.4 presents
the corresponding linear fit and fitting residuals.
4.2 Template Generation and Identification
Template generation refers to extracting desired waveforms based on the pre-test data to
construct a composite waveform for identifying the occurrence of the desired waveform
in the offline quiescence prediction epoch. The template identification was achieved by
1Note that each session of echocardiography acquires 10 second duration of B-mode frames.
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1st candidate: -1.09r + 90.68, R1 = 8.05
2nd candidate: -0.45r + 67.20, R2 = 4.29
Figure 4.4: Voting mechanism selects the linear model associated with less residual. R1
and R2 are residuals measured by the least square error. The group formed by the 2nd
candidates is associated with less fitting residual (R2 = 4.29) compared to the 1st candidate
group (R1 = 8.05), thus, the linear model derived from the 2nd candidate group is more
suitable to generalize the relationship between the quiescent phase and heart rate.
a template matching approach. In this work, the desired waveform is the high frequency
accelerometric component related to the heart sounds. As elaborated in Chapter 3.3, the
raw data was first pre-processed to obtain a conditioned signal for the follow-on processing.
To extract the waveforms associated with the first and second heart sounds, tempo-
ral windows were designed individually based on statistics from previous studies on heart
sounds [54, 74]. The primary configurations of the searching window are the window
length and region of occurrence within a cardiac cycle. Normally, the S1 is lower in fre-
quency and lasts for a longer duration than the S2 [54]. The average duration of the S1 and
S2 components are approximately 0.14 second and 0.11 second, respectively [74]. Since
the custom-built device synchronously acquired ECG and SCG signals at a rate of 1.2 kHz,
accordingly, the systolic and diastolic searching window were set with 160 and 100 sam-
ples in length, respectively. The heart sound associated waveforms occur prior to the corre-
sponding quiescent period, indicating that the region of occurrence can be estimated based
on the timing of the quiescent period. In a prior study, the timing of the quiescent periods
was studied by analyzing SCG signals acquired from seven healthy subjects and eleven
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patients with valvular or structural cardiac disease [45]. It was found that on average, the
center of systolic and diastolic quiescent periods were at 29% and 76%, respectively, for
healthy subjects, and 33% and 79%, respectively, for patients with CVD. Therefore, the
searching range of the two heart sound associated waveforms were set from Sstart = 1%
to Send = 30% and Dstart = 30% to Dend = 65% for healthy subjects, and 1% to 33% and
33% to 79% for the cardiac patients.
The procedures for generating the heart sound associated waveform templates corre-
spond to HS1 and HS2 consists of the following steps:
1. Extract the waveform associated with the heart sound with the aforementioned win-
dowed searching approach in each cardiac cycle. For a specific subject, denote the
the waveform from the i-th cardiac cycle w(i), i = 1, ..., N .
2. Use the longest waveform as the reference length, and padding zero at the end of the
rest of the waveforms to achieve equal length as the reference length, and obtain the




3. Apply Hilbert transform to obtain an upper (eupper) and lower envelope (elower) around
the composite waveform w̄. The difference envelope is the difference between the
two envelopes w̄d = eupper − elower [55]. The envelopes are displayed in Figure 4.5.
4. Locate the peak of the difference envelope w̄d, τP , measured as the sample index
within the difference envelope. The delay from the most recent R-peak to the τP
becomes τPR = τP + L̄ ∗ searchstart, where searchstart = Sstart or Dstart and L̄ is
the average cycle length.
5. Recapture waveform associated with the heart sound by extracting the waveform
around τPR in each cardiac cycle and τPR being the center of the window and with
the window details the same as aforementioned.
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6. Generate the waveform template by averaging the recaptured waveform and normal-
ize to unit energy. The unite energy is calculated by taking the square root of the sum
of squares on a sequence.





















Figure 4.5: The composite waveform and envelopes. The difference envelope is the differ-
ence between the upper and lower envelope formed using Hilbert transform on the com-
posite waveform. The peak of the difference envelope is considered the optimal peak of the
composite waveform.
The generation of the composite waveform and difference envelope in steps 2 and 3 are
for multiple purposes. The composite waveforms are able to narrow down the noise and
artifacts and increase the robustness in determining the optimal peak of the heart sound
associated waveform. The difference envelope increases the temporal resolution in detect-
ing the optimal peak of the heart sound associated waveform. The peak of the difference
envelope, as illustrated in Figure 4.5, indicates the temporal position corresponding to the
peak of the waveform. Steps 1 - 4 approximately capture waveform of the high frequency
accelerometric components and step 5 - 6 more accurately recaptures the waveform based
on the timing of the optimal peak τPR.
The application of the Hilbert transform facilitates the construction of the template
waveform. Any real signal s(t) can be written uniquely in the form s(t) = e(t) cos(2πfct+
θ(t)) where e(t) is the envelope and θ(t) is the phase of s(t). The relationship of the signal
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and its Hilbert transform is s̃(t) = 1√
2
e(t)ejθ(t). It is noted that the Hilbert transform
was originally exploited for periodic functions. The accelerometric waveform associated
with the two heart sounds in this study are sinusoidal-like (and thus quasi-periodic), so
the Hilbert transform works well in constructing the desired envelopes. However, it is
important to note that the Hilbert transform may fail in accurately capturing the envelopes
of some skewed waveforms.
As part of the offline prediction epoch (refer to Figure 4.2), the heart sound associ-
ated waveforms in a streaming SCG signal can be identified by correlating the generated
template waveform with the conditioned SCG signal in the time domain. As a result of
the correlation, the resulted peaks indicate where the center of the desired HS1 and HS2
waveforms locate.
4.3 Phase Delay Function
The phase delay function characterizes the relationship between the heart rate and the delay
in phases (%) from the cardiac feature, i.e., the optimal peak of HS1 or HS2 in SCG, to
the corresponding cardiac quiescence derived from the echocardiography. Obtaining the
phase delay function requires generation of the SCG waveform function and the echocar-
diographic quiescence function discussed in Section 4.1.
It has been discussed in Section 4.1 that a linear function has the potential to model
the relationship between the cardiac feature and heart rate, indicating that there may exist
a linear relationship between the optimal peak (in phase) of the SCG waveforms and the
heart rate. Figure 4.6 shows the systolic and diastolic SCG waveform function derived from
a set of pre-test signals.
For both of the linear functions, one was the SCG waveform function and the another
was the echocardiographic quiescence function, an outlier removal technique was applied
to get an unbiased linear function. Specifically, outlier removal was applied to both the
variables, the identified cardiac feature and heart rate. For the set of identified features,
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Figure 4.6: Heart sound associated waveforms in phase (%) as a linear function of the heart
rate (bpm).
any sample that strays away from the linear fit by more than two standard deviations was
removed. For the heart rates, any sample that strays away from the average heart rate for
more than three standard deviation was removed. A new linear fit was then constructed
after removing the outliers from both variables.2 Therefore, the difference between the two
linear functions generates another linear function, namely, the phase delay function. The
systolic and diastolic phase delay functions are presented in Figure 4.7.
The phase delay functions for systole and diastole can be mathematically represented
as





P diasdelay(r) = P
dias
echo(r)− P diasscg (r), (4.2)
where P sysscg (r) and P
dias
scg (r) are phases of the systolic and diastolic optimal peaks detected
from the SCG waveforms, respectively, for heart rate r. P sysecho(r) and P
dias
echo(r) are systolic
and diastolic quiescent phases derived from echocardiography, respectively.
2The cardiac features, i.e., the optimal peaks, have more natural variance as compared to the heart rates,
so the outlier remover for cardiac phases was set to have a tighter range of tolerance.
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Figure 4.7: The phase delay functions in systole and diastole, respectively.
In this work, two forms of phase delay functions were obtained, one was the patient-
specific and the other was the cohort-specific function. The former one was derived using
the patient-specific echocardiography data. The latter one was derived from an average
echocardiography quiescence function, namely,





P diasdelay(r) = P̄
dias
echo(r)− P diasscg (r), (4.4)
where P̄ sysecho(r) and P̄
dias
echo(r) are the average systolic and diastolic echocardiography quies-
cence functions, respectively, obtained by taking the mean of the echocardiography quies-
cent quiescence functions of individuals within the same cohort, with the application of the
leave-one-out method. A cohort is a group consisting of either healthy subjects or cardiac







where j is the index of the subjects/patients exclusive of the current subject of study and
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N is the total number of subjects within the same cohort. Accordingly, two forms of
evaluation are to be presented in Section 5.5. Both forms assess the potential of SCG as a
gating tool. However, the cohort form is applied in the actual CTA data acquisition scenario
and the patient-specific echocardiography is only for validating the accuracy of the ECG-
and SCG-based prediction. This is because acquiring the patient-specific echocardiography
is limited by its operator-dependent property and thus is not feasible during CTA data
acquisition.
4.4 ECG Gating Function
Currently, prospective CTA is triggered relying on an ECG signal. Specifically, a prede-
fined piece-wise constant gating function with respect to the predicted heart rates is em-
ployed, as mentioned in Chapter 2.1.1. Previous literature has extensively studied the opti-
mal systolic and diastolic reconstruction intervals for ECG-based CTA using retrospective
analysis. This work selectively uses a comprehensive gating function from [28] (corre-
sponds to the first example in Figure 2.3),
Pecg(r̂) =

65% r̂ ≤ 60 bpm,
75% 60 bpm < r̂ ≤ 70 bpm,
85% 70 bpm < r̂ ≤ 83 bpm,
35% r̂ > 83 bpm,
(4.6)
where r̂ is the predicted heart rate. Pecg is the predicted quiescence phase (%) measured
as a delay from the start of the most recent R-peak of the ECG to the start of the quiescent
period. As an important aside, the given function provides the phase of the triggering signal
with respect to the beginning of the systolic and diastolic quiescent period rather than the
center of the acquisition window. A linear conversion reported in Chapter 2.1.1 was applied
to the gating function, making it a heart-rate-dependent piece-wise function for the purpose
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of this work.
4.5 Heart Rate Prediction
In prospective CTA, as part of the quiescence prediction, the upcoming heart rate is un-
known and needs to be predicted. Various typical statistical models were experimented
on the heart rate sequence. The four models that were experimented include taking the
mean of the previous six heartbeats3, linear regression (LR) [75] using the previous six
heartbeats, cubic spline (CS) [76] using the previous six heartbeats, and the autoregressive
model (AR) [77] of order 3. The comparison was based on the mean square error (MSE)
associated with each model. The results using the data of a subject whose average heart rate
is r̄ = 83.02 bpm (corresponds to heartbeat of 0.72 s) and heart rate variability σr = 5.76
ms are illustrated in Figure 4.8. It was observed that the LR model resulted in the least
MSE. Thus, this work used the LR model for predicting the heart rate.
The mathematical form of LR6 can be expressed as
rn = LR6(ri) =
n−1∑
i=n−6
βnri + εn, (4.7)
where rn is the current heartbeat to be predicted, ri is the previous heartbeat with index i,
and εn is the n-th noise term, that is, random error. As a side note, LR is a useful linear
model that can be applied to real-valued time series to recognize the pattern of a set of
samples and thus is an appropriate model in predicting the instantaneous heart rate.
4.6 Pre-Test and Offline Prediction
To validate the proposed SCG-based prediction method, pre-test and offline prediction were
carried out on a set of data acquired from seven healthy subjects (mean age: 31; age range:
22-48; female/male: 3/4) and eleven cardiac patients (mean age: 56; age range: 31-78;
3To differentiate with the measurement in beat per minute (bpm) which is typically called heart rate, the
term heartbeat is used to represent the duration of a cardiac cycle in time, i.e. seconds or milliseconds.
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r̄ = 83.02 (bpm), σr = 5.76 ms
















Figure 4.8: Left: comparison of different heart rate prediction methods using a patient’s
heart rate sequence; Right: heartbeat traces of linear regression method. The mean heart
rate is 83.02 bpm and heart rate variability [78] is 5.76 ms. Mean: mean of the previous
six heartbeats; LR: linear regression; CS: cubic spline using the previous six heartbeats;
AR: autoregressive model of order 3. The red marks indicate the median values, and the
bottom and top edges of the box indicate the 25th and 75th percentiles, respectively, and
the whiskers are outliers.
female/male: 5/6). The data acquisition process and subject protocol were described in
Chapter 3.
For each subject, the synchronized ECG and SCG data were divided into two parts,
one for pre-test and one for offline prediction. Inspired by the rule of thumb in machine
learning, the ratio of the number of cardiac cycles for pre-test and prediction is 4 to 1 [75].
The two datasets are exclusively independent continuous cardiac cycles.
In the offline prediction epoch, the SCG waveform template generated in the pre-test
epoch correlates with the streaming SCG data in the prediction dataset to identify the timing
of the heart sound associated waveforms tscg. With the heart rate prediction algorithm
presented in Section 4.5 that predicts the heart rate r̂ (bpm) for the current cardiac cycle, the
phase of the current waveform becomes Pwscg = tscg × r̂/60. Therefore, then the predicted
quiescent phase from SCG is Pscg(r̂) = Pwscg + Pdelay(r̂) where Pdelay(r̂) = Pecho(r̂) −
Pwscg(r̂) as reported in Section 4.3.
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4.7 Performance Metrics
Four performance metrics were examined as listed below:
1. Waveform identification rate. The percentage of valid waveforms that were identi-
fied over cardiac cycles in the pre-test dataset. This measures the robustness of the
proposed waveform identification algorithm.
2. The variation of phase error along with the change of heart rate.
3. The variation of phase error against the heart rate error.
4. The overall phase error versus heart rate variation for each subject.
The phase error is defined as the absolute difference between the predicted quiescent
phase and that derived from the patient-specific echocardiography baseline,
Escg(rn) = |Pscg(r̂n)− Pecho(rn)|, (4.8)
or,
Eecg(rn) = |Pecg(r̂n)− Pecho(rn)|, (4.9)
where n is the index of a specific cardiac cycle; rn represents the true heart rate and r̂n is
the predicted heart rate. While the predict phases depend on the predicted heart rate, the
baseline quiescent phase is obtained from the echocardiography linear function against true
heart rate.
The heart rate error is the numerical difference between the true heart rate and the
predicted heart rate, presented as
Ehr(rn) = rn − r̂n. (4.10)
The average heart rate error for a specific subject is the mean of the absolute value of
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For each subject, the average phase error is the mean of all the phase error over all














Heart rate variability is a measure of the variation in heartbeats within a certain time
frame. The unit of measurement is in millisecond (ms) [47]. While there are multiple ways
to calculate the HRV, for example, the number of pairs of adjacent normal RR intervals that
differ by more than 50 ms, this work used the mean-square of the successive differences in






(rn − µhb)2, (4.14)
where µhb is the mean of heartbeats of cardiac cycles in the prediction dataset. The duration
of heartbeat is measured in time. The relationship of the heartbeat (hb) measured in time





As discussed in Section 4.3, the SCG-based prediction can be derived using two ap-
proaches, depending on the type of the phase delay function, either patient-specific or
cohort-specific. Therefore, SCG-based prediction derived from both approaches were eval-
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uated against the aforementioned metrics.
4.8 Results
The ECG- and SCG-based prediction results are summarized in Table 4.1, with the phase
errors presented both for patient-specific and cohort-specific forms. While the cardiac
phase normalized over a cardiac cycle for HRV is effective in mathematical modeling,
the evaluation of temporal error is what essentially contributes to the degradation in CTA
image quality, since the sensitivity to mistiming varies among individuals and the predicted
HR. Therefore, the corresponding errors in time (millisecond) are also presented. Note that
the cardiac cycles where waveform detection failed were omitted, and therefore were not
included in the calculation of phase errors. In the actual CTA data acquisition scenario,
cardiac cycles in which the waveform detection fails will by default apply the ECG-based
prediction. On average, the prediction errors of SCG-based prediction in systole and dias-
tole are 42.97 ms (5.53%) and 62.01 ms (8.21%), respectively, and 50.88 ms (7.17%) and
72.38 ms (8.52%) with ECG-based prediction.
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Table 4.1: Error Statistics
Healthy Subjects
Subject Avg HR (bpm) HRV (ms)
Average Phase Error (%)
Absolute Average Error (millisecond)
Personalized SCG Cohort SCG ECG
Systole Diastole Systole Diastole Systole Diastole
H1 58 41 3.30± 5.26 5.50± 6.01 4.75± 4.07 6.62± 4.18 - 5.84± 4.06
30.76± 48.77 52.36± 6.01 52.03± 50.75 62.12± 41.20 - 56.16± 42.30
H2 60 48 1.5± 2.38 2.54± 4.40 4.23± 1.94 8.61± 2.96 5.73± 3.37 4.89± 3.13
13.06± 23.67 22.47± 4.4 37.06± 23.18 70.27± 21.97 43.23± 20.18 42.47± 27.63
H3 68 28 2.94± 4.99 3.46± 6.34 2.43± 4.04 6.12± 4.80 10.62± 10.61 6.07± 3.88
25.22± 40.96 30.66± 6.34 22.39± 33.58 54.91± 33.31 63.81± 55.47 56.22± 35.65
H4 73 50 2.36± 4.74 2.72± 3.66 4.44± 4.78 2.46± 4.13 3.25± 3.81 9.15± 2.72
18.99± 39.27 21.76± 3.66 36.82± 40.28 17.95± 30.60 31.66± 52.76 74.2± 23.83
H5 77 50 2.00± 2.48 1.70± 3.20 3.06± 2.07 4.04± 3.67 11.37± 2.94 7.77± 3.16
14.59± 19.45 11.97± 3.2 21.84± 16.19 24.66± 21.00 76.16± 14.57 59.45± 27.19
H6 84 19 2.40± 3.96 0.92± 2.45 5.56± 1.47 2.78± 2.80 8.82± 0.88 5.30± 1.03
17.25± 28.20 6.71± 2.45 39.70± 8.28 18.51± 14.18 62.36± 5.02 38.86± 8.48
H7 92 58 0.88± 0.94 1.68± 1.31 5.10± 1.79 4.83± 2.23 3.55± 1.23 7.68± 0.47
6.04± 6.05 11.41± 1.31 34.55± 11.95 32.11± 13.49 23.37± 6.92 53.82± 5.25
Mean 72 42 2.20 2.65 4.23 5.07 7.22 6.67
72 42 17.99 22.48 34.91 40.08 50.10 54.45
Std 12 13 0.82 1.50 1.11 2.20 3.54 1.55
12 13 8.12 15.5 10.42 21.89 20.59 11.60
Cardiac Patients
Subject Avg HR (bpm) HRV (ms)
Average Phase Error (%)
Absolute Average Error (millisecond)
Personalized SCG Cohort SCG ECG
Systole Diastole Systole Diastole Systole Diastole
P1 52 20 2.11± 3.31 9.69± 11.17 1.95± 3.23 11.24± 6.01 2.51± 2.08 14.66± 3.22
22.90± 35.23 107.36± 11.17 22.36± 35.05 124.19± 69.68 22.14± 16.45 157.34± 25.00
P2 54 65 1.21± 1.71 5.45± 6.29 1.85± 1.52 10.91± 4.59 - 17.91± 4.47
13.10± 18.30 59.51± 6.29 20.45± 14.52 120.84± 56.24 - 192.72± 42.73
P3 54 208 2.84± 3.42 4.59± 4.10 6.16± 3.28 13.40± 3.77 1.22± 0.40 10.82± 0.85
19.11± 2.40 31.33± 4.10 32.054.15 21.76± 7.40 8.11± 2.46 76.22± 10.06
P4 63 63 2.08± 3.42 2.81± 4.10 3.09± 3.28 6.77± 3.77 - 3.64± 3.06
19.72± 32.19 26.97± 4.10 28.79± 29.41 62.33± 30.45 - 34.47± 27.08
P5 64 38 2.22± 2.22 4.27± 3.40 2.68± 2.03 3.48± 4.79 - 7.75± 1.29
18.2218.03 35.14± 3.40 21.7± 16.36 25.08± 30.10 - 63.64± 11.41
P6 65 60 4.47± 2.56 5.92± 7.40 0.05± 2.39 9.75± 8.90 3.08± 1.12 8.93± 4.54
38.79± 19.39 52.12± 7.40 24.51± 15.26 66.85± 71.45 31.56± 15.53 76.43± 41.73
P7 73 57 3.34± 3.37 2.89± 5.20 13.09± 3.63 11.64± 4.20 14.96± 0.8 0.2± 0.41
24.68± 25.26 21.38± 5.20 96.15± 27.08 84.78± 29.35 108.36± 3.44 1.48± 2.33
P8 81 170 3.59± 5.10 15.37± 14.33 3.27± 4.64 12.05± 13.12 13.74± 13.68 11.54± 8.64
31.87± 49.61 141.55± 14.33 31.09± 49.62 95.59± 115.28 91.58± 75.69 96.26± 78.36
P9 84 147 2.98± 3.54 9.47± 9.67 28.31± 4.48 11.98± 7.43 18.46± 0.42 11.6± 1.93
21.15± 25.54 67.98± 9.67 201.48± 36.33 76.87± 53.61 131.32± 17.54 81.42± 16.18
P10 87 29 2.57± 4.17 6.31± 5.74 2.13± 4.03 12.28± 6.18 2.45± 0.73 16.59± 2.90
18.38± 29.91 44.69± 5.74 15.21± 28.96 85.6± 45.63 17.16± 5.90 123.13± 26.06
P11 102 3 3.67± 1.84 0.48± 0.37 12.01± 2.91 27.92± 0.61 0.51± 0.12 -
20.92± 10.54 2.76± 0.37 67.58± 14.58 159.48± 3.65 2.95± 0.74 -
Mean 70 78 2.76 5.95 6.82 11.34 7.12 10.37
70 78 22.62 53.71 51.03 83.94 51.65 90.31
Std 16 66 0.94 4.21 8.16 6.18 7.28 5.52
16 66 7.11 40.15 55.5 41.19 50.55 56.06
† H represents healthy subjects and P represents cardiac patients.
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In Table 4.2 and Table 4.3, the two cohorts, healthy subjects and cardiac patients, are
further grouped based on their heart rates, as low heart rate (< 75 beats per minute) or high
heart rate (≥ 75 beats per minute). The numerical results report the average phase error
and the corresponding standard deviation of each group.
Table 4.2: Average error calculated with patient-specific phase delay function
Ēsystolescg (%) Ēdiastolescg (%) Ē
systole
ecg (%) Ēdiastoleecg (%)
Absolute Average Error (millisecond)
Healthy Subjects
Low HR (< 75 bpm) 2.52± 0.78 3.55± 1.35 6.53± 3.75 6.48± 1.84
22.01± 7.66 31.81± 14.28 46.23± 16.28 57.26± 13.01
High HR (≥ 75 bpm) 1.76± 0.78 1.43± 0.44 7.91± 3.98 6.91± 1.40
12.63± 5.86 10.03± 2.89 53.97± 27.38 50.71± 10.64
Cardiac Patients
Low HR (< 75 bpm) 2.61± 1.05 4.94± 2.34 5.44± 6.39 9.13± 6.08
22.36± 8.12 47.69± 29.63 42.54± 44.93 86.04± 67.03
High HR (≥ 75 bpm) 3.20± 0.52 7.90± 6.21 8.79± 8.96 13.24± 2.89
23.08± 6.00 64.24± 58.17 60.75± 61.02 100.27± 21.14
Table 4.3: Average error calculated with the cohort-specific phase delay function
Ēsystolescg (%) Ēdiastolescg (%) Ē
systole
ecg (%) Ēdiastoleecg (%)
Absolute Average Error (millisecond)
Healthy Subjects
Low HR (< 75 bpm) 3.96± 1.04 5.95± 2.56 6.53± 3.75 6.48± 1.84
37.07± 12.10 51.31± 23.11 46.23± 16.28 57.26± 13.01
High HR (≥ 75 bpm) 4.57± 1.33 3.88± 1.03 7.91± 3.98 6.91± 1.40
32.03± 9.19 25.09± 6.81 53.97± 27.38 50.71± 10.64
Cardiac Patients
Low HR (< 75 bpm) 4.12± 4.36 9.59± 3.37 5.44± 6.39 9.13± 6.08
35.14± 27.22 72.26± 41.06 42.54± 44.93 86.04± 67.03
High HR (≥ 75 bpm) 11.43± 12.08 16.06± 7.90 8.79± 8.96 13.24± 2.89
82.60± 103.26 86.02± 9.37 60.75± 61.02 100.27± 21.14
Note that in Table 4.1, there are average phase errors in systole that do not apply to
ECG. This is because the ECG-gating function is a one-ton-one mapping of a predicted
heart rate to a quiescent phase. For subject H1 whose overall heart rate is low, all the
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predicted quiescent phases fall within diastole. Therefore, this subject only has prediction
errors in diastole.
Table 4.2 reports the results generated using the patient-specific phase delay function.
The SCG-based prediction demonstrated less prediction error (measured in ms) and less
standard deviation for all subjects, while ECG yielded more prediction errors and larger
variance in all cases.
Table 4.3 shows the results generated from the cohort phase delay function. For healthy
subjects, the SCG-based prediction yielded less prediction error (measured in ms) than
ECG, both in systole and diastole. For cardiac patients, particularly with high heart rate,
SCG-based prediction in systole produced slightly more average errors (measured in ms)
than ECG. However, the diastolic prediction errors measured in time was significantly re-
duced using the SCG-based prediction.
4.8.1 Waveform Identification Rate
The waveform identification rate is referred to as the number of valid waveforms associated
with heart sounds identified within each cardiac cycle over the totally number of cardiac
cycles in the prediction dataset. Figure 4.9 shows the identification rate of the first and
second waveform of each individual. The first seven data samples correspond to the seven
healthy subjects and the following eleven data samples correspond to the cardiac patients.
The average identification rate over the 18 subjects for the first waveform is 78.8%, and
67.5% for the second waveform. The algorithm performed poorly on subject H6 due to the
noisy SCG data. Among the 17 other subjects, 15 had higher identification rates for the
HS1 waveform as compared to the HS2 waveform. Therefore, in general, the HS1 tends
to be easier to identify, this may relate to the stronger intensity of HS1 and its relatively
fixed timing of occurrence within a cardiac cycle. In addition, the duration of diastole
varies more with respect to heart rate variation, leading to a higher level of variability in
the timing of HS2.
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Figure 4.9: Waveform identification rate. H represents healthy subjects and P represents
congenital cardiac patients. The subject number corresponds with those in Table 4.1.
In summary, factors that could affect the identification rate are
1. The quality of signal. Noisy signals contain more high-frequency components on top
of the true signal making it harder to distinguish the high-frequency waveforms.
2. The morphology of the signal itself. Abnormal morphology appears in signals of
cardiac patients, making the identification process difficult.
4.8.2 Phase Error vs. Heart Rate
Depicted in Figure 4.10 are selected scatter plots of the phase error with respect to the
actual heart rate from a healthy subject and a cardiac patient, respectively. The associated
phase delay functions are cohort-specific.
The healthy subject shown in the left of Figure 4.10 has a higher heart rate and larger
heart rate variation than the cardiac patient shown in the right. In both plots in Figure 4.10,
ECG phase error decreases linearly as the heart rate increases, indicating that ECG could be
a better predictor at higher heart rate. In addition, particularly for the cardiac patients, SCG
phase error increases as heart rate increases, further implying that ECG could be a better
indicator for high heart rates. Overall, the SCG-predicted phases still demonstrated higher
accuracy than ECG-predicted phases, if neglecting the outliers. The systolic and diastolic
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SCG-based predictions demonstrated comparable performance as the heart rate changes.











































Figure 4.10: Example of the absolute phase error versus heart rate. The left figure cor-
responds to a healthy subject (subject H4), and the right figure corresponds to a cardiac
patient (subject P7). The absolute phase errors were calculated based on the phase delay
function within each cohort.
Plots of the average absolute phase error with respect to the average heart rate of all the
18 subjects are shown in Figure 4.11. SCG-prediction was derived using the patient-specific
phase delay function on the left and was generated using the cohort-specific phase delay
function on the right. The average phase error of SCG-based prediction using the patient-
specific approach were generally lower . The systolic SCG-based prediction performs bet-
ter than that of ECG-based prediction with both patient-specific and cohort-specific ap-
proach, while the performance of the diastolic SCG-based prediction was comparable to
that of ECG.
4.8.3 Phase Error vs. Heart Rate Error
The phase error is expected to increase as the heart rate error increases. Therefore, in-
tuitively, the expected plot of phase error against heart rate error for a specific subject is
supposed to be a V shape centered at zero heart rate error. Note that not all the waveforms
associated with heart sounds in SCG were identified successfully, however, the predicted






















































Figure 4.11: Average absolute phase error against average heart rate of all the 18 subjects.
The absolute phase errors in the left figure were calculated based on the patient-specific
phase delay function, and in the right figure was from each cohort.
to-one ECG gating function discussed in Section 4.4. Therefore, the individual number of
scatter samples associated with the systolic and diastolic SCG-based prediction is no more
than that of ECG in Figure 4.12. The SCG-based prediction for both subjects in Figure 4.12
similarly exhibit a V-shape. Both figures were generated using the patient-specific phase
delay function. The absolute phase error increases as heart rate error increases more signifi-
cantly when using the ECG-based prediction method as compared to that of the SCG-based
prediction method.
Figure 4.13 illustrates plots of the average phase error with respect to the average heart
rate error of all the 18 subjects, generated using the patient-specific phase delay function.
The average heart rate error was derived from the absolute value of heart rate errors. The
HS1 waveform of SCG yielded comparatively better prediction than that of ECG as well
as the HS2 waveform. As heart rate error increases, the average phase error becomes much
higher by using ECG-based prediction than that of SCG-based prediction.
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Figure 4.12: Example of the absolute phase error versus heart rate error. The figure on the
left corresponds to a healthy subject (subject H7), and the figure on the right corresponds
to a cardiac patient (subject P2). The absolute phase errors are calculated based on the
patient-specific phase delay function.




















































Figure 4.13: The average absolute phase error with respect to the average heart rate error
of all the 18 subjects. The absolute phase errors on the left were calculated based on
the patient-specific phase delay function, and the right were based on the cohort-specific
function.
4.8.4 Average Phase Error vs. Heart Rate Variation
Figure 4.14 shows the impact of heart rate variation on the average prediction error. The
plots were generated from results of each individual subject, using the patient-specific and
cohort phase delay function, respectively. SCG-based prediction with the patient-specific
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phase delay function yielded less phase error. With the cohort-specific phase delay func-
tion, the systolic SCG-based prediction predicted more accurately than the ECG-based
prediction.




















































Figure 4.14: The average absolute phase error with respect to the average heart rate varia-
tion of all the 18 subjects. The absolute phase errors on the left were calculated based on
the patient-specific phase delay function, and the right were based on the cohort-specific
function.
4.9 Remarks
This part of the work developed an SCG-based prediction strategy that utilizes the heart
sound associated waveform as a more proximal reference to the corresponding quiescence.
Compared with the traditional ECG-only-based prediction, the SCG-based method yielded
more accurate prediction both in systole and diastole.
However, no formal convention was established about when systolic or diastolic gating
should be applied. An empirical but not yet validated conclusion indicates that systolic gat-
ing yields better image quality for higher heart rates. However, the predicted phase errors
presented in Tables 4.2 and 4.3 did not match such conclusion. Considering echocardiog-
raphy as the baseline, the velocity magnitude of the deviation measure within a CTA data
acquisition window of 83 ms is a legitimate indicator to evaluate the suitability of systolic
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or diastolic gating. Based on the observations of the deviation measure in this work, sys-
tolic gating did not always relate to less cardiac motion, implying that the heart rate should
not be the only factor to consider.
The results demonstrated that SCG in general is an effective predictor of quiescence,
however, as the heart rate increases, ECG-based quiescence prediction becomes more ef-
fective. Therefore, combining SCG and ECG could potentially lead to an improved cardiac
gating of CTA.
A primary limitation of this work is that the hardware data acquisition system pro-
vided SCG signals in sub-optimal conditions. The heart sound associated waveforms were
heavily distorted by noise, and an important source of the noise was the accelerometric
sensor with a low signal-to-noise level. However, the waveform-based prediction method
is particularly sensitive to the heart sound morphology. Section 4.2 outlined the waveform
identification in which each cardiac cycle is supposed to produce one systolic and one di-
astolic peak after correlation, indicating the center of the waveform. However, due to the
heavily distorted SCG signal, the peaks may not be obvious enough, or occur in an un-
expected phase of the cardiac cycle. If an unexpected peak occurs beyond the searching
range, it is suitable for prediction and thus will be discarded. In this case, the waveform-
based prediction does not provide an optimal output if it fails in locating the waveform,
further suggesting the need for fusing ECG and SCG.
Another limitation of this work relates to the heart rate prediction. The prediction is
challenged by the heart rate variation. The current prediction method presented in Section
4.8 may be improved for tracing the actual heart rate more accurately when confronting
large heart rate variation. Advanced prediction methods such as the autoregressive inte-
grated moving average (ARIMA), general regression neural network (GRNN) and support




The SCG-based prediction was demonstrated to be effective in improving the quiescence
prediction as compared to the traditional approach, the ECG-based prediction, indicating
that SCG can potentially replace or supplement ECG to trigger cardiac gating. To date,
ECG is still a predominant technique for diagnosing cardiac-related conditions [80, 81].
The R-peaks of ECG are straightforward and robust markers to segment the heartbeats.
Although some explored segmenting heartbeats using cardiac features in the SCG signals
[82, 83], no universally acknowledged approaches were developed thus far. Therefore,
replacing ECG with SCG for general diagnostic purposes is not yet feasible; however,
using SCG to supplement ECG for quiescence prediction is more reasonable to investigate.
While SCG deliberately captures the mechanical cardiac movement, the accelerometric
sensor is highly sensitive to any motion, not only to the cardiac motion but also body
movement and external environmental interference. This compromises the accuracy of
the quiescence prediction since the SCG-based prediction method is waveform-dependent.
Therefore, it is important that the subject is well-rested during the CTA exam. In the case
when SCG-based prediction fails due to the excessive noisy waveforms, the ECG-based
prediction can be employed. Therefore, a fusion-based prediction1 that intelligently makes
use of both ECG and SCG for cardiac gating is introduced.
A schematic diagram that demonstrates the fusion-based, or weighted fusion (WF),
based prediction is shown in Figure 5.1. The fusion-based prediction was implemented
replying on an artificial neural network (ANN). Each component in the diagram will be
elaborated individually in the following sections.
1In this work, the terms “weighted fusion (WF)” and “fusion-based prediction” are used interchangeably
for the purpose of simplicity in some circumstances.
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Figure 5.1: The schematic diagram that demonstrates the fusion-based prediction. Pecg and
Pscg are predictions from the ECG- and SCG-based methods, respectively. wecg and wscg
are weights of ECG- and SCG-based predictions, generated from the ANN.
5.1 Overview of the Multimodal Framework
The fusion-based prediction is an essential part of the comprehensive multimodal frame-
work for quiescence prediction. The multimodal framework is an extension of fusion-based
prediction by encompassing special cases of the fusion-based prediction, and the cases
when the fusion-based prediction is not the optimal method. The multimodal framework
can be outlined with simplified block diagrams shown in Figure 5.2. The framework in-
corporates three modules. Module 0 is making a pre-defined ANN by training on data
from a cohort of subjects. The ANN can be pre-defined prior to the pre-test. The details
of pre-defining the ANN parameters is elaborated in Section 5.4. Module 1 is conduct-
ing the 3-minute pre-test in which synchronized ECG and SCG data are recorded. The
pre-test is dedicated to generating the personalized heart sound associated template and to
pre-categorize a subject based on the SCG index2. The pre-categorization decides to ap-
ply the ECG-based prediction or the fusion-based prediction during the actual CTA exam,
leading to two options in module 2 where the real-time data is processed for CTA gating.
The pre-test and pre-categorization are discussed in Section 5.6.
2The SCG index threshold, -120, was selected empirically. As the population in the cohort increases, the
selected threshold may vary but will get closer to its actual empirical value with a higher confidence level.
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Figure 5.2: Schematic diagrams outlining the comprehensive multimodal framework.
5.2 Artificial Neural Network Configuration
The ANN is a machine learning tool inspired by biological neural network structures of the
animal brain [84, 85]. ANNs utilize computer programs to simulate the way that the brain
processes the information, thereby recognizing complex patterns that can be learned by a
machine.
Fundamental elements that consists an ANN include an input layer, one or more hid-
den layers, an output layer, and neurons. Neurons, or nodes, within a layer change their
states with different inputs and produce outputs based on the activation. Neurons are in-
terconnected between layers. Each neuron from the hidden layer(s) and output layer is a
weighted transformation of the neurons from the previous layer. The hidden layer imposes
transformation on neurons whereby weights and bias are assigned to groups of neurons and
their linear combination is passed through an activation function as the input to the next
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layer. The values of weights and bias are initially randomly assigned and can be updated
in a back propagated manner until the final output of the ANN best matches the desired
outcome. A simple two-layer ANN structure is presented in Figure 5.3.
Figure 5.3: A two-layer ANN structure with an input layer (3 neurons), one hidden layer
(4 neurons) and an output layer (2 neurons).
ANNs have multiple merits. Studies have demonstrated the competence of ANNs in
capturing associations among vaguely understood variables [86] without imposing con-
straints upon the input data structure [87]. In addition, ANNs are efficient in dealing
with real-time signal detection and classification, as well as with transient signals with
low signal-to-noise ratio [88]. The training of ANN models may be time consuming, but
once the training/learning process is completed, the model parameters will be saved for
prediction, making the ANNs more time-efficient than algorithms such as the k-Nearest
Neighbor and Support Vector Machine. ANNs also do not have constraints upon the input
data structure, while Linear Discrimination Analysis and Quadratic Discriminant Analysis
assume the conditional distribution is multivariate Gaussian [87]. In terms of prediction,
an ANN outputs not only a classification decision but also Bayesian probability estimates,
which can potentially serve as the relative weighting between SCG and ECG parameters in
the multimodal framework.
To date, machine learning, especially classification algorithms such as ANNs, has been
widely applied to solve biomedical-related problems such as identification of arrhythmias
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from ECG [89] and screening sleep apnea from polysomnography [90]. Because the ANNs
are especially useful in approximating nonlinear functions and dealing with a large num-
ber of inputs that are generally unknown [91, 92], ANNs have been applied extensively
to classifying physiological signals [92, 93]. One example is the development of an auto-
mated generic classifier for detecting physiological signals whose type are unknown [93].
More examples can be found in a review on ANN for processing and classifying multiple
biomedical signals [92].
With regard to cardiac gating, prior research focused mainly on quiescence prediction
that relies exclusively on either ECG or SCG [8, 42], resulting in a limited background
literature to refer to. In this work, fusion-based prediction was implemented using a pre-
defined three-layer artificial neural network (ANN) whose output, Bayesian probability
estimates, served as the assigned weights, wecg and wscg, for fusing individual predictions
from ECG and SCG. The weights can be interpreted as the likelihood that a specific cardiac
cycle to be optimally gated using one modality, either ECG or SCG. Gating with solely
ECG or SCG are special cases of weighted fusion where one of the weights takes the value
of 0 and the other takes 1. Let Pecg and Pscg be quiescence predicted from ECG- and SCG-
based method, respectively, the ultimate fusion-based prediction is a linear combination
of the individual predictions from the ECG and SCG and can be expressed as Pwf =
Pecgwecg + Pscgwscg where wecg + wscg = 1.
The input to the ANN is a set of personalized features extracted from the ECG and
SCG signals and will be elaborated in Section 5.3. In summary, the selected features in-
clude heart rate, heart rate variability [94], waveform correlation [95], heart sound (HS)
associated waveform power intensity [96] and wavelet-based time-frequency coefficients
[97, 98].
The specific configuration of the ANN applied to this work was obtained based on a few
rational principles. A two-layer ANN is able to represent any arbitrary continuous function,
and an ANN with greater than two layers is able to represent any function [99]. Thus, a
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three-layer ANN configuration is an appropriate choice for this study in which the associ-
ated data structure is unknown. Figure 5.4 illustrates the feedforward ANN configuration
used in this study. The ANN consists of three layers: two hidden layers with hyperbolic
tangent-sigmoid and log-sigmoid as activation functions [100], respectively, and an output
layer with softmax activation function [101]. The number of neurons in each layer was
set heuristically. The network was trained with scaled conjugate gradient back-propagation
[102]. The back-propagation feeds the error term back through the layers, by updating the
weights at each node. The number of nodes in each layer was determined by using the
trial-and-error method.
Figure 5.4: The three-layer ANN configuration [101]. The input is a set of features con-
sisting of 11 single-valued entries linked with two hidden layers with activation functions
tansig and logsig, each consisting of 10 neurons. [W, b] are configuration parameters rep-
resenting the weights and bias. Two softmax output neurons in the output layer generate
two values corresponding to the predicted probabilities, referred to as weights, of ECG-
and SCG-based gating in the weighted-fusion (WF).
Similarly, the selection of two activation functions followed an intuitive logic. The ac-
tivation functions were first heuristically chosen among a few commonly used activation
functions. Then the trial and error method of multiple different combination of activa-
tion functions enabled discovery of the optimal pair that yielded the highest classification
accuracy.
Typically, the activation functions can be categorized into linear and non-linear types
as shown in Figure 5.5. Piecewise linear functions such as rectified linear unit (ReLU)
function and pure linear function do not confine the output of the function within a closed
and bounded domain. Additionally, linear functions fail in adapting with the complexity
and nonlinearity of input data. Therefore, linear activation functions are not suitable for
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this work.











Pure Linear: f1(x) = x
ReLU: f2(x) = max(0, x)











tansig: f3(x) = 21+e−2x − 1
logsig: f4(x) = 11+e−x
Figure 5.5: Examples of linear and non-linear activation functions.
The commonly used non-linear functions for artificial neural networks are hyperbolic
tangent (also known as tanh) and sigmoid (also known as logistic) functions. Hyperbolic
tangent function ranges from -1 to 1, hence, it is zero centered, making the gradient update
faster and easier. The sigmoid function restricts any input value within 0 and 1 which is
especially helpful for models that predicts the probability as an output. Therefore, this
work chose to use the hyperbolic tangent sigmoid activation function (tansig) for the first
hidden layer and log-sigmoid (logsig) for the second hidden layer.
5.3 Feature Selection and Extraction
This part of the work prepares the input to the ANN, wherein a few sequential procedures
are involved. The procedures are embodied in the block diagram in Figure 5.6.
Figure 5.6: Block diagram of signal processing procedures to obtain input for the ANN.
Synchronized ECG, SCG and sessions of echocardiography signals were acquired and
the raw signals were pre-processed to remove the noise and artifacts. Details about data
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acquisition and pre-processing were delineated in Chapter 3. After pre-processing, signals
were segmented into individual cardiac cycles and each cardiac cycle was re-sampled into
1000 sample length for computational simplicity. Quiescence prediction for cardiac gating
is required on a beat-by-beat basis, therefore, subject-specific features were extracted on a
beat-by-beat basis.
The rationale for selecting ANN features is three-fold. First, the feature set should
contain as much information of the original dataset as possible. Second, the features are
expected to be invariant to irrelevant transformations of the data. Third, features are ex-
pected to be distinguishing. More specifically, a new feature is only worth adding when it
serves to increase information in the current feature set.
Feature selection involves two stages. The first stage is constructing an original feature
set that contains a broad coverage of features. The original features and their corresponding
number are summarized in Table 5.1. These features were selected based on published
research demonstrating their effectiveness in representing cardiac information in ECG and
SCG signals. This is not intended to be an exhaustive or optimized list of features.
Table 5.1: Original Features
Original ECG Features Original SCG Features Total
HR HRV SNRecg Cecg DWTecg PSDoutput PSDHS1 PSDHS2 DWTscg
1 1 1 1 4 1 1 1 3 14
The 8 ECG features in the original feature set are elaborated below:
1. HR: Heart rate. Reciprocal of the interval between two consecutive R-peaks. Mea-
sured in beat per minute (bpm).
2. HRV: Heart rate variability [94, 103]. Defined as the deviation to the mean of the
most recent eight R-R intervals with respect to a specific cardiac cycle. The deviation
was measured by the absolute difference [104]. The first eight cardiac cycles are for
initialization.
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3. SNRecg : Signal-to-noise ratio. An ensemble template was obtained by averaging the
re-sampled cardiac cycles. The difference between the ensemble template and an
individual re-sampled cardiac cycle was the difference time-series whose magnitude
indicate the signal distortion due to noise. The root-mean-square (RMS) power of the
difference time-series quantitatively measures the relative noise power with respect
to an individual cardiac cycle. The estimated signal-to-noise ratio is the ratio of
template waveform power (summation of squared sample values) to the noise power
with respect to an individual cardiac cycle.
4. Cecg : Waveform correlation [95, 105]. The correlation between an individual cardiac
cycle and the aforementioned ensemble template as an evaluation of the morpholog-
ical distortion level due to noise and artifacts.
5. DWTecg : Discrete wavelet transform (DWT) coefficients [97, 106, 107]. For ECG,
Daubechies four (Db4) was tested to be a suitable mother wavelet and a decomposi-
tion level of 8 was found to be suitable [106, 108]. Four wavelet scales (5-8) were
used, corresponding to the frequency band spanning approximately 2-20 Hz. The
mean coefficient of each scale was then used as the original features.
The 6 SCG features in the original feature set are elaborated below:
1. {PSDoutput ,PSDHS1 ,PSDHS2}: Heart sound waveform intensity [96]. The power
spectrum based on discrete Fourier transform within three frequency ranges: 0-10
Hz that relates to the cardiac output, 10-30 Hz that relates to the first heart sound
(HS1), and 30-50 Hz that relates to the second heart sound (HS2) [70, 109, 110].
Periodogram estimates the power spectrum density of the time-series cardiac signal
by squaring the magnitude components of the discrete Fourier transform of the signal.
The aggregate power within each 10 Hz bin was calculated by summing the power
within the aforementioned three spectrum ranges providing a periodogram estimate
of the PSD.
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2. DWTscg : Discrete wavelet transform (DWT) coefficients. Previous work demon-
strated the superiority of “Coif5” mother wavelet in decomposing the heart sound
related signals [70]. Similar to ECG, a decomposition level of 8 was applied to SCG.
Three wavelet scales (4-6) were used, corresponding to the frequency band spanning
approximately 10-45 Hz. The mean coefficient of each scale was then used as the
original features.
Compared to the classic discrete Fourier transform (DFT), the wavelet-based time-frequency
decomposition, DWT, is a more advanced technique in analyzing the temporal resolution
of a signal. The mother wavelet was selected based on the similarity in waveforms. Visu-
alizations of the mother wavelets of ECG and SCG signals are presented in Figure 5.7. In
addition to the frequency information, the DWT also captures local temporal information.
The various option and scales of dilation of the mother wavelet enables the DWT to local-
ize the time-frequency relation within a signal at a finer level. To ensure that the wavelet
coefficients are free from boundary effects, the decomposition level was chosen to be no
greater than log2(L) for a signal of length L.






























Figure 5.7: Mother wavelets (A) “db4” for ECG signal and (B) “Coif5” SCG signal.
To reduce the number of features as input to the ANN, only the DWT coefficients
corresponding to the frequency range of interest were taken. Based on the Fourier transform
analysis of the human ECG signal, it was found that the QRS complex frequency ranges
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within 4 Hz and 20 Hz, the heart rate component is within 0.67 Hz and 5 Hz (corresponds
to 40-300 bpm) and the P and T wave frequencies generally lie between 0.5 and 10 Hz [68].
Therefore, for the ECG signal, the wavelet decomposition coefficients corresponding to the
frequency span of 2-20 Hz were used. Similarly, the wavelet decomposition of SCG within
10 Hz and 45 Hz were intended to make use of the information from the high frequency
accelerometric waveforms associated with the first (10-30 Hz) and second heart sound (30-
45 Hz). Thus, for the SCG signal, the wavelet decomposition coefficients corresponding to
the frequency span of 10-45 Hz were used. The time-frequency visualization of continuous
wavelet decomposition of ECG and SCG signals are illustrated in Figure 5.8.
Figure 5.8: Time-frequency presentation derived from wavelet decomposition of (A) ECG
signal and (B) SCG signal.
The ANN is sensitive to skewed values of features, e.g., extremely large or small values
as the input. Heavily noisy cardiac cycles can potentially yield skewed features. To avoid
deadlock in ANN processing, it is necessary to identify those cardiac cycles that may not be
good candidates for feature selection. Therefore, each individual cardiac cycle is evaluated
on its ECG waveform and its SCG HS waveform before feature selection. The criteria for
selecting the good candidate cardiac cycles are as follows:
1. Cardiac cycles with Cecg < 0.3 and HS not identified by the waveform template
detection approach [38] are considered to be severely contaminated by noise, and
thus are eliminated. No quiescence prediction is made for this cardiac cycle.
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2. Cardiac cycles with Cecg > 0.3 but with no HS identified are suitable for ECG-based
prediction, indicating that Pscg = 0 and thus Pwf = Pecgwecg.
3. Cardiac cycles with HS identified but Cecg < 0.3 are suitable for SCG-based predic-
tion, indicating that Pecg = 0 and thus Pwf = Pscgwscg.
4. Only those cardiac cycles whose ECG and SCG waveforms are clean enough are
valid for fusion-based prediction by the ANN, indicating that Pecg 6= 0 and Pscg 6= 0
and Pwf = Pecgwecg + Pscgwscg.
The threshold criterion is set based on empirical statistics of Cecg . Cases 2 and 3 are special
cases of 4, the fusion-based prediction. On average, 72% of the cardiac cycles were good
candidates for feature selection.
The second stage of feature selection picks a subset of the original features to form
a more select and computationally efficient feature set. The 14 single-value original fea-
tures can be narrowed down by identifying the relative importance of each feature and
constructing a more select feature set by discarding the less significant features. To this
end, the neighborhood component analysis (NCA) [111] with regularization was applied
to the original feature set. NCA is a non-parametric and embedded method that selects
features with the goal of maximizing prediction accuracy of classification. The embedded
method is one of the three typical feature selection algorithms, the other two are the filter
method and wrapper method. The embedded method ranks the contribution of features in
the process of creating the model. Regularization introduces additional constraints to im-
prove the leave-one-out classification accuracy [112], which then generates an optimized
feature weighting. The average weight of each original feature is presented in Figure 5.9
where the 3 features with the lowest weights, the DWT of ECG at level 5 and 8 as well as
DWT of SCG at level 5, were discarded.
A select feature set of 11 single-value features was then created, consisting of 6 fea-

























































































Figure 5.9: Relative feature weight (%) evaluated by the neighborhood component analy-
sis. Features in purple bars demonstrated less importance in distinguishing ECG and SCG
signals and consequently were discarded.
features. The number of 11 features may still seem large and an even more selective feature
set with 4 features are presented in Chapter 6. Other related work used various number of
features from ranging from 3 to 15, or ever larger [113, 114]. Many of these works only in-
vestigated one signal while this work involves two cardiac signals, thus, naturally, a larger
number of features may be needed to present cardiac information of both signals. As an
additional note, this work is not intended to be an exhaustive or optimized list of features.
Table 5.2: Select Features
Select ECG Features Select SCG Features Total
HR HRV SNRecg Cecg DWTecg PSDoutput PSDHS1 PSDHS2 DWTscg
1 1 1 1 2 1 1 1 2 11
The feature selection is followed by the feature extraction, wherein a new set of features
was constructed based on the existing features in the select feature set. Feature extraction
is an irreversible transformation to reduce the dimensionality of the feature set. The princi-
pal component analysis (PCA) was applied where eigenvalues less than 20% of the largest
eigenvalue were discarded. Features were then normalized by calculating their Z-scores
[115, 116] to eliminate the bias of mean and variance before inputting into the ANN. Note
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that PCA uses an orthogonal transformation to convert the set of possibly correlated fea-
tures into a set of linearly uncorrelated features. While the dimension of the feature set
is reduced upon mapping to the principal axes, the number of features that comprises the
feature set remain the same.
5.4 Training, Testing and Cross-Validation
To validate the proposed fusion-based prediction method, training and testing of the ANN
were carried out on a set of data acquired from seven healthy subjects (mean age: 31; age
range: 22-48; female/male: 3/4) and eleven cardiac patients (mean age: 56; age range:
31-78; female/male: 5/6). Hence, two cohort of subjects were formed, one consisting of all
healthy subjects and the other consisting of all cardiac patients.
Training and testing were carried out in a leave-one-out manner. The testing dataset
was formed by the designated subject’s cardiac data. The corresponding training dataset
was formed using cardiac data from the rest of participants who belong to the same cohort.
To avoid over-training by the excessive number of cardiac cycles contributed by the rest
of participants in the cohort, a subset of size four times of that of the testing dataset was
blindly selected. On average, the evaluation for each subject involves 6336 cardiac cycles
for training and 1584 cardiac cycles for testing.
The ECG-based prediction was obtained from a pre-defined piece-wise gating function
[28] described in Chapter 2.1.1. This gating function maps a predicted heart rate to an one-
on-one quiescent phase. According to Equation 4.6, for heart rate greater than 83 bpm, a
systolic quiescent phase is assigned for CTA data acquisition, and heart rate no greater than
83 bpm is assigned with diastolic quiescent phase. To make it a fair comparison between
the ECG- and fusion-based prediction, quiescent predictions from the same cardiac period,
either systolic period or diastolic period, are compared.
The predicted heart rate was obtained from a linear regression formed by using the
previous six heart beats. SCG-based prediction was obtained using the patient-specific HS
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waveform detection method elaborated in Chapter 4.
The ANN binary classifier categorizes an input feature into two groups, labeled as
“ECG” and “SCG”. Labels in the testing dataset were obtained by comparing the ECG-
and SCG-based predictions with the quiescence derived from the baseline subject-specific
echocardiography, respectively. The modality that led to a smaller prediction error was
considered to be an optimal modality for a particular cardiac cycle, and thus this modality
was assigned as the label for that cardiac cycle. The prediction error, in milliseconds,
was calculated as the absolute difference between the predicted quiescent timing and the
baseline subject-specific echocardiography.
The properties of training and testing datasets are different. The feature values in the
training dataset are deterministic, while the testing dataset contains predicted values as
features. More specifically, in contrast to the training dataset, features {HR,HRV } from
the testing dataset were unknown since the upcoming cardiac cycle of this particular subject
is unknown. As mentioned earlier, the upcoming instantaneous heart rate was predicted
using a linear regression method with previous six heartbeats [38]. The instantaneous heart
rate variability was the deviation of the predicted instantaneous heart rate from the mean of
the most recent eight heart rates [104].
The training dataset was further divided into four uniform parts randomly, one of which
was used for cross-validation [75]. This 4-fold cross-validation was repeated 10 times with
random partition of the training dataset to make the whole process as 10x4-fold cross-
validation. The output from ANN, including classification accuracy and modality proba-
bility, were the average results over the 10 iterations.
5.5 Results
The performance of the multimodal framework was evaluated from multiple aspects. The
ANN prediction accuracy and precision reflect the effectiveness of the constructed ANN
in binary classification. By combining the individual predictions from ECG and SCG, the
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ANN produces a fused prediction. The quiescence prediction error was then calculated as
the deviation of the fused prediction from the quiescence derived from the subject-specific
baseline echocardiography. Lastly, the diagnostic quality of the CTA images reconstructed
at the phases derived from ECG-, SCG- and fusion-based methods were evaluated and
compared.
As mentioned in Section 5.2, one of the merits of ANN is its output of both prediction
and classification functions. In this work, the output from the softmax function in the out-
put layer are two entries within the range of 0 and 1, and the two entries add up to 1. In
probability theory, the output of the softmax function can be considered as a categorical
distribution, namely, a probability distribution over different possible outcomes. Classifi-
cation is made based on the probability of each category, e.g., ECG or SCG, as compared
to a specified threshold. The ANN classification performance, accuracy and precision, is
presented in Section 5.5.1.
The fusion-based method utilizes the probability output from the ANN as weights of the
linear combination of individual predictions from the ECG and SCG. The quiescence pre-
diction error presented in this section was measured in time, e.g., seconds or milliseconds.
As mentioned in Chapter 5.5, while the cardiac phase, normalized over a cardiac cycle for
HRV, is effective in mathematical modeling, it is essentially the temporal error that results
in the degradation of the cardiac CTA image quality. On the other hand, the error in phase
neglects the sensitivity to mistiming that varies among individuals and the predicted heart
rate. The quiescence prediction performance, prediction error and variation, is presented in
Section 5.5.2.
5.5.1 Artificial Neural Network Classification Accuracy
The decision-making of the ANN binary classification was made by comparing the cat-
egorical probability with a threshold. Theoretically, a correct ANN binary classification
leads to a value close to 1 for the weight associated with the correct category and close to 0
64
for the other category. A typical threshold is 0.5 (corresponds to 50% in probability) when
each category hold similar percentage. The results from Chapter 4 indicate that the SCG-
based prediction is more accurate for the majority of cycles, thus, the SCG is the dominant
category in classification. In this case, a biased threshold is set based on the proportion of
different categories over the total number of categorized predictions. More specifically, the
accuracy for testing/prediction was set according to the subject-specific data in the training
dataset: Tecg = Necg/N and Tscg = Nscg/N , where N = Necg +Nscg is the total number of
ECG-labeled (Necg) and SCG-labeled (Nscg) cycles. By comparing the ANN output, wecg
and wscg, with Tecg and Tscg, respectively, classified/predicted labels were decided.
The ANN prediction accuracy and precision are listed in Table 5.3, in order of increas-
ing heart rate, within each cohort. Subjects H1 to H7 are from the cohort of healthy subjects
and P1 to P11 are from the cohort of cardiac patients. The classification accuracy is the
percentage of correct labels being identified, and precision is the percentage of correctly
predicted SCG-labeled cycles against the total number of cycles predicted as SCG-labeled
cycles.
The average accuracy of the ANN is 89.9% for the healthy cohort and 80.6% for cardiac
patients. The average precision of the ANN is 93.5% for the healthy cohort and 83.8% for
cardiac patients. These values indicate that the selected features are fair representatives of
the cardiac information from acquired signals. However, there is room for improving the
classification performance. Several factors may affect the classification performance:
1. Acquired data: Outliers in the data may cause overlapping patterns. The training
dataset is expected to have adequate number of instances for an effective learning for
the ANN.
2. Selected features: The presence of irrelevant features or an inadequate number of
effective features.
3. Classification algorithm: In general, this factor does not significantly impact the clas-
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Table 5.3: Three-Layer ANN Binary Classification
Healthy Subjects
Subject HR (bpm) HRV (ms) Accuracy (%) Precision (%)
H1 58 41 90.1 95.4
H2 60 48 89.4 92.7
H3 68 28 90.4 93.8
H4 73 50 92.2 94.7
H5 77 50 87.1 91.0
H6 84 19 90.2 93.7
H7 92 58 89.9 92.9
Mean 72 42 89.9 93.5
Cardiac Patients
P1 52 20 80.6 82.8
P2 54 65 80.7 83.5
P3 54 208 77.3 81.3
P4 63 63 80.7 83.1
P5 64 38 81.3 84.1
P6 65 60 82.8 84.1
P7 73 57 83.3 86.5
P8 81 170 79.5 84.3
P9 84 147 81.3 85.8
P10 87 29 78.8 82.7
P11 102 3 79.9 83.3
Mean 70 78 80.6 83.8
sification accuracy when the dataset is large and the selected features for classifica-
tion are salient representatives of the cardiac information of the raw signal. In this
case, other classification algorithms are very likely to give similar results as the ANN
in this study [75].
5.5.2 Quiescence Prediction Errors
Figure 5.10 reveals the individual average prediction error (in milliseconds) from the testing
dataset. The optimal quiescent prediction method, either ECG, SCG or WF, was selected
based on the least error (ms). The overall prediction error associated with ECG-, SCG-
and WF-based method over all subjects are 76.15 ms, 48.30 ms and 43.95 ms, respectively.
Out of the 18 subjects, only one subject (P2) would actually benefit from using ECG-based
gating solely. It is also observed that subjects H3 and H4 are potential candidates for ECG-
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based prediction, but fusion-based prediction works as well for them.

















































Figure 5.10: Quiescence prediction error (milliseconds) derived from different quiescent
prediction methods. The overall prediction error associated with ECG-, SCG- and WF-
based method over all subjects are 76.15 ms, 48.30 ms and 43.95 ms, respectively.
Figure 5.11 reports the quiescence prediction error derived from ECG-, SCG- and
fusion-based method. The median of the three groups of prediction error are 71.01 ms,
40.34 ms and 44.32 ms. WF- and SCG-based prediction elicited comparable low errors
than that from ECG, but WF caused less variability among the three methods.
Although the absolute prediction improvement in milliseconds by using WF- or SCG-
based prediction may not seem very prominent for all individuals, it is noticeable that
for some subjects whose ECG-based predictions yielded large prediction errors, such as
patients P3 and P11, the SCG- and WF-based predictions were able to reduce the error
significantly. For such subjects, SCG- or WF-based quiescent prediction could potentially
lead to saliently improved diagnostic quality.
Figure 5.12 illustrates a subset of cardiac cycles from subject P11 with predicted tem-
poral quiescence (time of quiescence occurrence within a cardiac cycle with respect to



















Figure 5.11: Box plot of quiescence prediction error (milliseconds) over all 18 subjects. On
each box, the central mark indicates the median (value in red), and the bottom and top edges
of the box indicate the 25th and 75th percentiles, respectively. The median prediction error
for ECG-, SCG- and WF-based method are 71.01 ms, 40.34 ms and 44.32 ms, respectively.
No outlier was observed. ECG-based prediction resulted in the most error. WF and SCG-
based predictions are comparable. The smallest variability is seen in the prediction error
associated with WF.
SCG-based prediction is closer to the baseline echocardiography than ECG-based predic-
tion. Fusion-based prediction fuses predictions from ECG and SCG, and performed the
best. This is consistent with results in Figure 5.10 where WF-based quiescence prediction
is the most effective quiescent prediction method for patient P11.
To better appreciate the utility of fusion-based prediction, let Ēpred be the quiescent
prediction error, from either the SCG- or WF-based prediction method. The error reduction
R against the ECG-based prediction is calculated by
R = (Ēecg − Ēpred)/Ēecg × 100%, (5.1)
where Ēpred could be Ēwf or Ēscg. Figure 5.13 reports the error reduction derived from
different prediction methods. This error reduction measures the percentage of average
error that can be reduced from ECG-only-based quiescent prediction. The median of the
reduced error corresponding to SCG- and fusion-based method are 49.78 ms and 46.96
ms, respectively. WF- and SCG-based methods reduced comparable percent of prediction
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Figure 5.12: A subset of predicted temporal quiescence derived from different gating
modalities for patient P11. Overall, WF gating is the optimal gating modality for P11
according to the average error presented in Figure 5.10.














Figure 5.13: Box plot of percentage of error reduction (%) against the quiescent prediction
error from the ECG-based prediction over the 18 subjects. On each box, the central mark
indicates the median (value in red), and the bottom and top edges of the box indicate the
25th and 75th percentiles, respectively. The outliers are plotted individually using the “+”
symbol. WF and SCG-based predictions are comparable, however, the variability in the
reduced error associated with WF is smaller than with SCG.
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5.5.3 CTA Reconstructed Image Quality
To place this work in the clinical setting, a board certified cardiothoracic radiologist, with
over 7 years of experience interpreting cardiac CTA, evaluated the images and scored the
quality of the coronary artery images using a 4 point Likert response format: 1 = excellent,
2 = good, 3 = adequate, 4 = non-diagnostic. The radiologist was blinded to the modality
that selected the phase for the reconstruction. Significance was tested using the Wilcoxon
signed-rank test.
Figure 5.14 illustrates the four main coronary arteries: left main (LM), left anterior de-
scending (LAD), left circumflex (LCX) and right coronary arteries (RCA), from the origin
to the first branch.
Figure 5.14: Four main coronary arteries. LM: left main; LAD: left anterior descending;
LCX: left circumflex; RCA: right coronary arteries.
Table 5.4 reports the individual grading on LM, LAD, LCX and RCA. The histograms
in Figure 5.15 further summarize the grade distribution of diagnostic quality associated
with different prediction methods.
It was observed that the WF quiescence prediction is associated with a higher frequency
of achieving lower Likert scale grade, indicating that WF yielded the best diagnostic quality
overall. The SCG-based prediction achieved better diagnostic quality than the ECG-based
method because SCG has slightly higher frequency in achieving the lower Likert format
grade. The WF prediction consistently achieved the best diagnostic quality for all patients,
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Table 5.4: Diagnostic Quality Grades
Patient No. P1 P2 P3 P5 P6 P7 P8 P9 P10 P11 Mean p-value
Left Main (LM)
ECG 1 2 2 1 1 1 1 1 1 3 1.40
SCG 1 1 2 1 1 1 1 1 2 1 1.20 0.75
WF 1 1 1 1 1 1 1 1 1 1 1.00 0.25
Left Anterior Descending (LAD)
ECG 1 2 3 1 2 4 2 1 2 4 2.20
SCG 1 2 3 1 2 3 2 1 4 2 2.10 1.00
WF 1 2 1 1 2 4 2 2 1 2 1.80 0.38
Left Circumflex (LCX)
ECG 1 2 3 1 2 4 2 2 2 4 2.30
SCG 2 2 3 1 2 4 2 1 3 2 2.20 1.00
WF 1 1 4 1 2 4 3 2 1 2 2.10 0.75
Right Coronary Arteries (RCA)
ECG 1 2 4 2 2 4 2 3 4 4 2.80
SCG 2 3 4 1 2 4 2 2 3 2 2.50 0.53
WF 1 1 2 1 3 4 3 3 2 3 2.30 0.25
* The CTA data of patient P4 is missing.
** Grade: 1 = excellent, 2 = good, 3 = adequate, 4 = non-diagnostic. p-values calculated
against ECG.
*** The p-values were derived from the two-sided Wilcoxon signed-rank test (α = 0.05).



























Figure 5.15: Histograms of the diagnostic quality grades. Four point Likert response scale:
1 = excellent, 2 = good, 3 = adequate, 4 = non-diagnostic.
whereas ECG achieves the least for all. The average grade over all the reconstructed vol-
umes and all four vessel segments for the ECG, SCG and WF are 2.18, 2.00 (p = 0.1957)
and 1.80 (p = 0.0118), respectively, assuming that there is no correlation among tests
performed in LM, LAD, LCX and RCA. The p-values were derived from the Wilcoxon
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signed-rank test (α = 0.05). The current p-values are not sufficient to make strong conclu-
sions about the effectiveness of the WF-based method in the diagnostic quality. However,
the relatively smaller p-value of the WF-based method than the SCG-based method sug-
gests a trend supporting WF-based method. Among the four segments, the RCA, which is
generally degraded the most by motion artifacts of the coronary vessels, achieved the high-
est improvement in diagnostic quality using WF-based method as compared to the ECG.
Examples of RCA and LCX segments from cardiac CTA reconstructions of cardiac
patient P11 are shown in Figure 5.16. Reconstructions associated with the WF-based pre-
diction resulted in the highest diagnostic quality, while ECG-based prediction resulted in
the lowest.
Figure 5.16: Comparison of the diagnostic quality of CTA images reconstructed at qui-
escent phases derived from different prediction methods. The CTA data presented were
from patient P11. Blue arrows point to an example of calcification. Green arrows point
to the motion artifacts. Compared to ECG-selected phases, the SCG-selected phases in
(b) and (e), and WF-selected phases in (c) and (f) demonstrate sharper outline of the RCA
and LCX. Calcification in the RCA is also more sharply defined by SCG- and WF-selected
phases. The significant motion artifacts rendered the pointed (green arrows) regions of the
RCA in (a) and LCX in (d) non-diagnostic for the ECG-selected quiescent phases.
Due to configuration limitations from the clinical CTA scanner, reconstructed CTA vol-
umes for an individual are retrospectively generated at a constant phase over all cardiac
cycles, rather than on a beat-by-beat basis. This constant phase is the average of the beat-
by-beat quiescent phases derived from a specific quiescent prediction method. If the recon-
struction is made on a beat-by-beat basis, the diagnostic quality associated with SCG- and
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WF-based quiescence prediction could potentially provide a more substantial improvement
over the ECG-based prediction.
5.6 Pre-Test and Pre-Categorization
As a crucial part of the SCG-based prediction, Chapter 4 proposed a pre-test of 3 minutes
prior to the CTA data acquisition for collecting cardiac data to generate a personalized
waveform template. This section investigates the value of the pre-test in the fusion-based
prediction.
The fusion-based prediction adaptively fuses individual predictions from the ECG and
SCG on a beat-by-beat basis. As mentioned in Section 5.3, special cases in which the SCG-
or ECG-based prediction fails for a particular cardiac cycle may occur. A comprehensive




Pecg wecg = 1 and wscg = 0,
Pscg wscg = 1 and wecg = 0,
wecgPecg + wscgPscg wecg 6= 0 and wscg 6= 0.
(5.2)
Although the results thus far showed that most of the subjects benefited from the fusion-
based prediction, it is imprudent to exclude the possibility of getting better predictions from
the ECG-only-based prediction, such as subject P2. The results in Section 5.5 indicate
the existence of a rare case in which an individual may benefit from the ECG-only-based
prediction, over all cardiac cycles. In this case, the fusion-based prediction becomes un-
necessary. The cause of such a situation can be excessive body movement that deteriorates
the SCG signal, abnormal heart sound associated waveforms that the template matching
approach in the SCG-based prediction cannot recognize, or attachment issues of the ac-
celerometer to the human body that leads to recording of random signals.
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An individual who would only benefit from the ECG-based prediction can be cate-
gorized as the ECG-inclined subject, similarly, an individual who would benefit from the
fusion-based prediction can be categorized as the WF-inclined subject. A pre-categorization
using the cardiac data from the pre-test along with the pre-recorded cohort echocardio-
graphy data can possibly identify subjects of different categories. The subject-specific
echocardiography is not feasible during the pre-test because of its operator-dependent prop-
erty, thus, the subject-specific echocardiography was only used as the baseline for quies-
cent prediction to validate the performance of different prediction methods. However, the
cohort-specific echocardiography is pre-recorded data from subjects within the same co-
hort, and thus is accessible during the pre-test.
The performance of the WF-based prediction relies on the relative goodness of SCG to
ECG, as SCG serves to provide additional prediction information to correct the predictions
derived from ECG alone. To quantify the goodness of the SCG relative to ECG, a subject-
specific SCG index is derived during the pre-test, based on which pre-categorization can be
made.
To derive the patient-specific SCG index, the quiescent phase generated from the cohort-
specific echocardiography is used as the estimated baseline, denoted as P̄echo(r) at heart
rate r (bpm). The generation of P̄echo(r) is elaborated in Chapter 4.3. During the pre-test
where synchronous ECG and SCG are recorded, the estimated baseline is compared with
the predicted quiescent phase derived from ECG- and SCG-based predictions, PECG(r̂)
and Pscg(r̂), respectively, at a predicted heart rate r̂. Thus, the estimated prediction errors
can be presented as
Êecg(r̂) = |P̄echo(r)− Pecg(r̂)|, (5.3)
Êscg(r̂) = |P̄echo(r)− Pscg(r̂)|. (5.4)
Taking the mean of the estimated prediction errors over all cardiac cycles gives the average
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estimated error for an individual, denoted as Ēecg and Ēscg for ECG and SCG, respectively.





The first term in the multiplication of Equation 5.5 measures the relative prediction error
of SCG to ECG, and the sign of the first term indicates which error, Ēecg or Ēscg, is larger.
The second term, Ēscg serves as a scaling factor that zooms in the Iscg value for larger
Ēscg. In this way, poor SCG signal that can potentially lead to large prediction error can
be better distinguished. Intuitively, as the estimated SCG-based prediction error increases
(i.e. Ēscg > Ēecg), Iscg becomes more negative.


























Figure 5.17: (A) The SCG index as a quantitative indication of the goodness of SCG rel-
ative to ECG. Larger SCG index indicates better performance of the WF-based prediction
as compared to the ECG-based prediction. (B) The probability of applying the WF-based
method, derived from the SCG index. The smaller the SCG index, the less likely it is to use
the WF-based prediction. P2 has a very small SCG index, yielding low probability in using
the fusion-based prediction, therefore, P2 is more suitable for using the ECG-only-based
prediction method.
The SCG index of each individual was calculated and displayed in Figure 5.17 (A).
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The results from the SCG index are consistent with those reported in Section 5.5.2. The
larger the SCG index, the more likely the subject can benefit from SCG- or fusion-based
predictions. The SCG index of subjects H3 and H4 are not high enough because they
are potential candidates for ECG-based prediction. Patient P2 has the lowest SCG index,
indicating that this subject has a large SCG-based prediction error and thus is more suitable
for using the ECG-based prediction.
To better distinguish the subjects from the two categories, a transform was made in a
way that converts the SCG index to a value that can be interpreted as the probability of
using the WF-based prediction. To convert the SCG indices within 0 and 1, the array of
SCG index from all subjects was subtracted by the minimal value and then divided by the
maximal value to form a new array. An exponential transform of e−
100
x for each value x
in the new array was then made to take the smaller values closer to 0 and the larger values
closer to 1. Lastly, the array was divided by the maximal value in the array. Figure 5.17
(B) presents the transformed SCG index, or the probability of using the WF-based method
for quiescence prediction. Consistent with the result in Figure 5.10, patient P2 has a very
low probability in using the fusion-based prediction.
5.7 Remarks
This part of the work developed a fusion-based quiescent prediction method by fusing
individual predictions from the ECG and SCG on a beat-by-beat basis, relying on a three-
layer ANN. Results from a pilot group of seven healthy subjects and eleven cardiac patients
demonstrated that the fusion-based method is effective and robust. The major findings
showed that the fusion-based prediction achieved 47% improvement in prediction error
against the traditional ECG-only-based prediction. In addition, the prediction error derived
from the fusion-based prediction method was less variant, and thus the fusion-based was
more robust. In the observer study, the fusion-based prediction resulted in better diagnostic
quality of CTA coronary vessels.
76
An additional investigation on the pre-categorization achieved the pre-test character-
istics the ECG- and SCG-inclined subjects, which facilitates in deciding the optimal pre-
diction method to apply. Overall, a comprehensive multimodal framework consisting of
components investigated in Chapters 4 and 5 was established.
One limitation of this work is the evaluation of the diagnostic quality of the CTA re-
constructed images. For each subject, one CTA volume was reconstructed over all cardiac
cycles during the CTA data acquisition, at an average predicted phase derived from a spe-
cific prediction method. This average predicted phase was derived by taking the mean of
the predicted phases from all cardiac cycles in the testing dataset. Therefore, each subject
has three CTA reconstructed volumes that correspond to ECG-, SCG- and fusion-based
prediction methods, respectively. Yet, during the CTA exam the prediction is supposed to
be made on a beat-by-beat basis, rather than a single phase for all cardiac cycles. This
was limited by the fact that the CTA data was not acquired simultaneously with the ECG
and SCG signal, thus, validation cannot be achieved in a per cycle manner. The concern
of acquiring CTA data simultaneously from the human body is the excessive amount of
radiation. Future work may possibly start with simultaneous data acquisition on an ani-
mal model. In a complementary fashion, additional radiology readers will be recruited to
explore the effect of inter-reader variability.
Another limitation lies in the features used in ANN of this study. The selected features
were individually demonstrated to be effective representations of cardiac signals based on
findings of previous research [70, 105–107, 109]. However, the applied feature set may
be sub-optimal and a superior feature set can be established by investigating other features
and attempting different combination of features.
With respect to the sample size, more participants are expected to be recruited, par-
ticularly coronary cardiac patients, to enlarge the subject population. The inclusion of
additional subjects would enhance the statistical significance of improvement in diagnostic
quality associated with the WF-based prediction. In addition, the expanded subject popula-
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tion can lead to a more generalized training dataset, because the pre-defined ANN depends
highly on the properties of the training dataset. The more comprehensive the extracted fea-
tures, the less biased the trained ANN becomes. Furthermore, the threshold for the SCG
index in pre-categorization can be optimized with more subjects’ data.
Implementation of the multimodal framework in real-time with relevant hardware in-
tegration is the natural next step. This requires a rigorous consideration of computational
complexity and time delay occurring in different stages of signal transmission and pro-
cessing. In addition, the co-investigation and enhancement of both hardware and software
makes it highly possible to achieve a better diagnostic image quality and reduced radiation




Previous chapters are dedicated to demonstrating the effectiveness of the cardiac-motion-
based signal in improving the accuracy of quiescence prediction, as well as the potential
of the multimodal framework for cardiac CTA gating. This chapter focuses on establishing
a real-time prototype for the multimodal framework. To this end, existing hardware and
software platforms were integrated, and algorithms developed in previous chapters were
adapted to achieve a near real-time implementation. Validation of the prototype was made
using both pre-recorded and real-time streaming data. Additionally, a hardware layout was
designed for developing an independent device dedicated to the multimodal prediction.
Overall, this work demonstrates the feasibility of the ECG-SCG dual gating1 framework
for cardiac CTA data acquisition.
Near real-time implementation is an important step toward applying the dual gating
strategy to the clinical setting. Other researchers have made initial attempts in dual gating,
and the results thus far are promising. In 2004, General Electric (GE) Medical Systems (a
subsidiary of GE, Boston, MA, USA) was awarded a patent regarding the invention of me-
chanical gating of CT [61, 62]. This invention proposed a method that uses a non-electrical
sensor for gating, and reported a schematic hardware design of integrating a mechanical
sensor to the CT machine. The proposed method correlates the set of ECG signals and me-
chanical motion signals to determine the cardiac phases at which CT reconstruction should
be carried out. The goal of this method is to improve the quiescent phase selection, but not
particularly for optimizing the quiescence prediction for prospective gating.
Another promising example of dual gating is the DTU200/300 dual channel MRI trig-
1Dual gating refers to utilizing two cardiac sensing modalities for the gating of a cardiac imaging machine,
while traditionally, gating is achieved with only one sensing modality, e.g., the ECG signal.
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gering and gating system (BIOPAC Systems, Goleta, CA, USA) [63] which was released
in 2008. The purpose of this system is to improve tumor and/or lesion qualification when
imaging the lung and abdominal regions by minimizing respiratory motion artifacts [117].
Dual mode in this system refers to a cardiac signal, either ECG or continuous blood pres-
sure (BP) signal, in combination with the respiratory (RSP) signal. The modality of the
cardiac signal (ECG or BP) can be manually selected to work together with the respiratory
signal for MRI gating, based on the subject-specific data acquired prior to the MRI exam.
The quiescent phases in the RSP signal are determined relying on a user selectable thresh-
olding method. The output pulses indicating the trigger of MRI imaging is timed as a delay
relative to the BP peak or R-peak of the ECG.
More recently, a group of researchers developed two approaches of dual gating for
PET imaging, both of which demonstrated the potential of cardiac-motion-based signal
in cardiac PET imaging. One approach is to use the SCG signal acquired from a tri-axis
accelerometer together with the ECG signal for cardiac PET gating [42]. Another is a mir-
croelectromechanical (MEMS)-based dual gating method that relies on two non-electrical
sensors, a tri-axial accelerometer and a gyroscope [43]. In the latter approach, cardiome-
chanical activities from the echocardiography observations were used to validate the accu-
racy of the dual-sensor solution. However, the feasibility of these dual-sensor approaches
in real-time cardiac gating applications has not yet been established.
As a step further, this work developed a near real-time ECG-SCG quiescence prediction
framework, and investigated its feasibility and effectiveness. This chapter presents the work
from three aspects. The first two aspects introduce the hardware (Section 6.1) and software
(Sections 6.2 - 6.3) implementation of the framework. The third aspect (Section 6.4) reports
results from the human subject testing.
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6.1 Enhanced Data Acquisition System
Chapter 3.2 elaborates the custom data acquisition system and the results presented thus
far (Chapter 4 and 5) were achieved from the data acquired using the custom system. The
accuracy of the SCG-based prediction was compromised by the sub-optimal configurations
of the sensor/accelerometer in the ECG-SCG custom device, especially the relatively low
signal-to-noise ratio. Hence, an enhanced data acquisition system was designed to over-
come these technical issues.
Figure 6.1: Overview of enhanced data acquisition system setup. fs is the sample rate.
Figure 6.1 illustrates the data acquisition setup of the enhanced system. The procedure
of data acquisition remains the same as that of the custom system, as described in Chapter
3.2, where the ECG, SCG and B-mode echocardiography data were acquired simultane-
ously. However, the characteristics of the devices in the enhanced system are different and
are vital to the near real-time implementation. Thus, a detailed presentation of individual
devices comprising the enhanced system is exhibited in Figure 6.2, and the specifics of
each device are summarized in Table 6.1.
The BIOPAC MP150 System enables synchronized data acquisition and real-time anal-
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Figure 6.2: Devices used in this work.
Table 6.1: Hardware Specifics
Item Component Technical Details
1 BIOPAC MP150
(BIOPAC Systems, Goleta, CA, USA)
ECG and SCG data acquisition and analysis system
Sample rate: 200 Hz (adjustable, aggregate sample rate up to 400 kHz)
ADC resolution: 16 bit
2 UIMC100C
(BIOPAC Systems, Goleta, CA, USA)
Biopotential amplifier module for SCG
3 RSPEC-R
(BIOPAC Systems, Goleta, CA, USA)
Biopotential amplifier module for ECG
4 BioNomadix
(BIOPAC Systems, Goleta, CA, USA)
Wireless ECG transceiver
Transmitter carrier frequency: 2.4 GHz
Analog filter bandwidth: 0-150 Hz
5 Accelerometer
(Analog Devices, Norwood, MA, USA)
Cardiac-motion-based sensor (refer to Table A.1)
6 Signal Conditioner
(PCB Piezotronics Inc, Depew, NY, USA)
In-line charge and voltage amplifier for SCG
Spectral noise: 0.06 µV/
√
Hz (10 − 100 Hz); 0.10 µV/
√
Hz (1 −
10 Hz); 0.67 µV/
√
Hz (< 1 Hz)
7 Laptop
(Hewlett-Packard, Palo Alto, CA, USA)
Processor: Intel Core i7-4702MQ, 4 cores, clock speed at 2.2 GHz
Software: MATLAB 2017 (MathWorks, Natick, MA, USA)
8 Sonix RP Scanner
(BK Ultrasound, Richmond, BC, Canada)
B-mode echocardiography and ECG acquisition machine
B-mode frame rate: 50 Hz/frame
ECG sample rate: 200 Hz
9 Somatom Force
(Siemens, Erlangen, Germany)
CTA imaging data acquisition machine
Dual-energy 192-slice
Data acquisition window duration: 66 ms
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ysis of the ECG and SCG signals. Upon receipt by the MP150, analog signals are indi-
vidually filtered/conditioned by the corresponding biopotential amplifier modules. Both
analog signals are then sampled by an analog-to-digital (ADC) in the MP150 at a rate of
200 Hz. This meets the requirement of Nyquist sampling theorem for both signals2, while
minimizing the computational efforts. The internal buffer of MP150 can store up to 6M
samples. Digitized samples are then relayed to the laptop via an Ethernet crossover cable
at a bit rate of 10 Mbps [118]. Before computerized processing, the incoming samples are
temporarily stored in a buffer exploited by the MP150 in the laptop.
The enhanced data acquisition system advances the custom system in its capability of
processing the streaming data in real-time. In the enhanced system, the streaming data is
transferred to a computer for quiescence prediction in a near real-time manner, while the
original custom system simply records and saves the data for offline computerized process-
ing afterwards. Built upon previous work, this body of work continues to use MATLAB
(MathWorks, Natick, MA, USA) as the computerized processing tool for the near real-time
implementation. Future development can consider using low-level programming language,
i.e. C language, to improve the real-time performance.
The BIOPAC hardware API (BHAPI) enables interaction between the data acquisition
system, MP150, and third-party software programs, i.e. MATLAB, for basic data acqui-
sition [119]. Specifically, BHAPI allows for streaming data transfer and programming
interface via a dynamic link library (DLL). The precompiled routines, methods, functions
and objects of the DLL can be readily used by MATLAB to control the MP150.
The accelerometer in the enhanced acquisition system is a primary component that
significantly enhances the performance of quiescence prediction. Table A.1 in Appendix A
briefly compares the sensor characteristics of the sensors used in the enhanced and custom
data acquisition systems. The sensor in the enhanced system has significantly lower RMS
noise level and is much lighter. The entire footprint of this accelerometer is as small as a
2The bandwidth of interest for both ECG and SCG signals are from 0 to 50 Hz.
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fingernail (Figure 6.1, image No.5). Additionally, the sensor in the enhanced system was
tested for CTA imaging by attaching to a phantom. The result demonstrated insignificant
streak artifacts during the cardiac CTA scan.
Retrospective cardiac CTA data were acquired and reconstructed independently using
a Siemens Force dual-source 192-slice CT scanner (Siemens, Erlangen, Germany) with
data acquisition window duration of 66 ms. These CTA data are used for assessing the
diagnostic quality of quiescence predicted from different modalities.
The Siemens Force scanner not only achieves higher temporal resolution, but also sig-
nificantly reduces the radiation dose, as compared with the previous generation of the dual-
source cardiac CTA, the Siemens SOMATOM Definition (introduced in Chapter 3). It was
reported that the radiation dose resulting from prospective gating on the Siemens Force is
approximately 0.44 mSv [120], while it is approximately 2.8 mSv for the Siemens SO-
MATOM Definition [19]. The overall radiation dose resulting from retrospective gating of
the Siemens SOMATOM Definition is as high as 18.4 mSv [121], while the Siemens Force
can reduce the radiation to 12 mSv or lower [122].
The following sections discuss two major attributes of the software aspect of the near
real-time implementation: latency (Section 6.2) and computerized processing (Section 6.3).
Overall, the latency determines the feasibility, and the computerized processing contributes
to the effectiveness of the near real-time system.
6.2 Latency
Latency is an important aspect for evaluating the real-time computing and is crucial for
real-time prediction. The concept of “real-time” is not equivalent to achieving the fastest
processing [123]. Real-time requires processing fast enough to meet the deadline within
specified time constraints. In summary, the time constraints imposed on the near real-time
implementation of this work are twofold:
1. The latency, ∆t4, introduced by the computerized processing cannot exceed a speci-
84
fied tolerance ∆T ∗, namely,
∆t4 ≤ ∆T ∗, (6.1)
where ∆T ∗ is the duration for receiving and accumulating a frame of data samples
for processing. The value of ∆T ∗ relies on the frame size which is discussed in
Section 6.3.1.
2. The effective prediction for gating, ∆T ∗g , is a valid time duration, namely,
∆T ∗g > 0. (6.2)
This requires that the predicted timing for gating is not missed after synthesizing the
total latency.
Figure 6.3 illustrates the epochs of signal transmission, t0 − t3, for ECG and SCG sig-
nals, respectively. Additionally, epoch t3− t4 of computerized processing is also presented
in Figure 6.3. Due to different device configurations, the transmission duration of ECG and
SCG signals can be different for the same epoch. The total latency associated with a signal
is the sum of latency introduced by each epoch.
The first epoch, t0 − t1, starts with the transmission of cardiac signal from the heart to
cardiac sensors. The ECG signal, an electrical signal, has a negligible transmission through
the body. However, the transmission of the seismographic signal is not as straightforward.
The mechanical wave transmission relates to the heart-to-chest distance which varies due
to multiple factors such as age, gender and patient body habitus [124, 125]. A conserva-
tively large heart-to-chest distance of 4 cm is considered. Given that the compression wave
propagation speed in tissue is approximately 1540 m/s, the estimated mechanical signal
transmission duration is 26 µs.
The second epoch, t1 − t2, is the signal transmission from the sensor to the data ac-
quisition device. In transmitting the ECG signal to the MP150, the wireless transceiver
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(A) ECG signal transmission and processing epochs.
(B) SCG signal transmission and processing epochs.
Figure 6.3: Breakdown of epochs of (A) ECG and (B) SCG signals transmission and pro-
cessing. The latency introduced by each epoch i is denoted as ∆ti for i = 1, 2, 3, 4.
introduces a 15 ms biased delay and 500 µs unbiased delay3. The wired signal transmission
duration of the SCG signal to the signal conditioner is negligible. However, the SCG signal
conditioner introduces approximately 2.8 µs of delay for the amplification operation.
In the next epoch, t2 − t3, signals undergo conversion and amplification in the MP150
system and are then relayed to the computer. The multiplexer switching between two signal
channels causes a 5 µs delay and the ADC causes another 5 µs delay [126], resulting in a
total of 10 µs of delay in this epoch. 4
3The biased delay comes from the deterministic straight transmission and unbiased delay is caused by
jitter
4As an additional note, the dual ADCs in the MP150 system sample any chosen two channels simulta-
neously, so two channels of data can be acquired at a rate as high as 200 kHz with zero channel-to-channel
latency.
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Following signal transmission is the epoch of computerized processing, t3 − t4. The
computerized processing involves invoking functions in DLL to download the data from the
computer buffer and process the frame-based data for prediction. The latency ∆t4 depends
on the computerized algorithms and is intricate. Thus, Section 6.3 exclusively elaborates
the computerized processing, as well as addresses the latency ∆t4 and tolerance ∆T ∗.
In summary, the total latency introduced by the hardware transmission and computer-
ized processing is ∆T = ∆t1 + ∆t2 + ∆t3 + ∆t4. Specifically, the latency is ∆Tecg =
15.51 ms + ∆t4 for the ECG signal, and ∆Tscg = 38.8 µs + ∆t4 for the SCG signal.
The total latency is crucial for effective prediction. Let ∆Tg be the predicted duration
from a detected reference feature, i.e. R-peak of the ECG signal, to the predicted center
of the quiescent period. The effective prediction for gating is a shorter duration obtained
by synthesizing three durations: the total latency ∆T , data acquisition duration of the CT
scanner Tacq, rising time of the x-ray tube potential ∆tr, and the delay from the detected
feature to the most recent data sample ∆td.
In this body of work, the Siemens Force Scanner (Siemens, Erlangen, Germany) was
used and its data acquisition window is Tacq = 66 ms. The estimated duration for the x-ray
tube to rise to its full potential5 is ∆tr = 0.5 ms [127–129].
Therefore, the effective prediction for gating, ∆T ∗g is










or equivalently, ∆Tg > ∆T + 33.5 ms + ∆td.
If the prediction comes out ineffective, i.e. ∆T ∗g ≤ 0, CTA gating and data acquisi-
tion will not be carried out and the next cardiac cycle automatically becomes the target of
5Although typically a rising duration of less than 0.5 ms can be achieved, this work conservatively chose




The computerized processing is a crucial part of the near real-time processing because it
is closely related to the total latency and quiescent prediction accuracy. In summary, this
section regarding the computerized processing addresses
1. Frame-based quiescent prediction strategies using the ECG-, SCG- and fusion-based
methods in a near real-time manner.
2. The latency, ∆t4, introduced by the frame-based computerized processing.
3. The time tolerance, ∆T ∗, to the computerized processing.
6.3.1 Frame-Based Processing
Frame-based data is a typical format in real-time systems. It maximizes the efficiency of the
system by distributing the fixed process overhead across many samples. In addition, pro-
cessing a frame of samples at once reduces the computational time of the signal processing
algorithms.
Figure 6.4: Frame-based processing. The processing frame size is n = 97 and offset is
N = 20. fs is the sample rate.
The processing frame and sliding offset are important components of the frame-based
processing, as illustrated in Figure 6.4. The processing frame is a frame of samples that un-
dergo computerized processing in one iteration, and the sliding offset indicates the number
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of new samples per iteration in the processing frame. In this work, the sample size of the
processing frame is n = 97, and the sliding offset is N = 20 data samples. The number
of samples in the processing frame is restricted by the filter design. For pre-processing,
a Hamming window configuration of order less than 32 does not effectively attenuate the
high frequency noise and the order of 32 requires a minimal of 96 samples to process.
The duration of QRS in ECG signal for adults is 0.06-0.10 s, corresponding to maximal
20 samples at 200 Hz sample rate. Therefore, the latency introduced by the computerized
processing, ∆t4, cannot exceed the tolerance duration, ∆T ∗, for accumulating a frame of
the most recent N data samples, indicating that
∆t4 ≤ ∆T ∗ = N ×
1
fs
= 0.1 s, (6.4)
where fs = 200 Hz is the sample rate. This is to guarantee to take in consecutive data
samples for computerized processing without missing any.
Compared with the regular offline processing, the frame-based processing for real-time
is limited by the frame size. Algorithms that used to process the pre-recorded long-term
data may fail in dealing with the short-term data, or are not able to complete within a
specific time tolerance. For example, a popular method to identify the QRS complex of
the ECG signal in real-time was developed in an early work by W. Tompkins [104]. This
method used a special digital band-pass filter and adaptive thresholds to significantly reduce
the false detection rate. However, the “real-time” in this method is relative to approximately
2-3 cardiac cycles of delay due to the requirement of certain number of data samples to
update the threshold. Therefore, this method is not suitable to be applied to this work.
To better present the near real-time processing, a breakdown of the modules of the
processing system are illustrated in Figure 6.5. Major processing modules are highlighted
in blue and are elaborated in Sections 6.3.2 - 6.3.5.
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Figure 6.5: Computerized processing modules. Modules in blue are major processing mod-
ules discussed in Sections 6.3.2 - 6.3.5.
6.3.2 Pre-Processing and Pre-Test
The frame-based pre-processing includes filtering and obtaining initialization values from
the pre-test prior to the CTA data acquisition. This part of work corresponds to the filtering
function in the signal controls modules in Figure 6.5.
To minimize the artifacts and noise such as the skin-electrode interface interference and
respiratory drift, as well as to preserve the QRS components in the ECG signal, a band-pass
FIR filter with a Hamming window configuration and pass-band of 0.5-50 Hz was applied.
The same filter configuration was used for filtering the SCG signal to reserve the heart
sound associated waveforms that lie within 10-50 Hz. The order of filters for both ECG
and SCG signals were chosen to be 32. This was for the sake of computational efficiency
in real-time processing, while ensuring that undersired artifacts and noise are filtered out.
During the pre-test, a sequence of cardiac cycles are acquired and processed entirely
in an offline manner. Processing of the pre-test data includes filtering the ECG and SCG
signals, segmenting signals based on the R-peaks of the ECG, and detecting the heart sound
associated waveforms in the SCG signal. To ensure that the heart rate can be predicted
from the linear regression of the previous six heart beats, a minimum of eight cardiac
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cycles are acquired during the pre-test. The acquisition of eight cardiac cycles also enables
initialization for the detection of R-peaks in the ECG signal as well as the heart sound
associated waveforms in the SCG signal.
As a bounding limit of this work, the fastest heart rate of interest is 120 bpm and the
slowest is 40 bpm. Therefore, given the sample rate of fs = 200 Hz, the maximum number
of data sample within eight cardiac cycles is 2400, corresponding to 12 s of duration.
6.3.3 Quiescence Prediction
After pre-processing the ECG and SCG signals, individual predictions for the ECG and
SCG signals are derived. This part of work corresponds to the prediction functions in the
signal controls modules in Figure 6.5.
The ECG-based prediction was implemented using the ECG-gating function. The
mathematical form of the ECG-gating function [130] used by the Siemens Force scanner is
Pecg(r̂) =

70% r̂ ≤ 65 bpm,
75% 65 bpm < r̂ ≤ 70 bpm,
40% 70 bpm < r̂ ≤ 80 bpm,
35% r̂ > 80 bpm,
(6.5)
where r̂ is the predicted heart rate. Pecg is the predicted quiescence phase (%) measured as
a delay from the most recent R-peak of the ECG to the start of the quiescent period.
The SCG-based quiescence prediction is not as straightforward. It requires detection
of the heart sound associated waveform as the reference and estimation of the delay from
the reference to the predicted quiescence. The peak of the systolic heart sound associated
waveform (HS1) almost always 25 ms lags behind the most recent R-peak, corresponding
to 5 samples of delay at a sample rate of 200 Hz. The peak of the diastolic heart sound
associated waveform (HS2) is more challenging to identify since there is no such definite
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marker as the R-peak to facilitate the identification. Therefore, a thresholding technique
was applied to identify the peak of the diastolic waveform in real-time. The delay from the
detected SCG feature to the quiescence can be derived from a phase delay function, e.g.,
delay in percentage with respect to the predicted heart rate. Figure 6.6 presents a visualiza-
tion of the ECG- and SCG-based prediction implemented in a near real-time manner.
Figure 6.6: Visualization of the ECG- and SCG-based near real-time quiescence prediction,
respectively. The blue circles are identified heart sound associated features as references
for SCG-based predictions, and the green dotted lines indicate the predicted quiescence.
The ECG-base prediction derives only one prediction for each cardiac cycle, while the
SCG-based prediction is able to derive a systolic and diastolic prediction for each cardiac
cycle.
Although the SCG-based method is able to achieve both systolic and diastolic predic-
tions upon identification of the corresponding heart sound waveforms, to make it a fair
comparison among the ECG-, SCG- and fusion-based methods, only the predicted quies-
cence from the same cardiac period, either systole or diastole, are compared.
The cardiac quiescence derived from the patient-specific B-mode echocardiography
was used as the baseline while evaluating the performance of the ECG-, SCG- and fusion-




The fusion-based prediction employs a three-layer ANN that provides weights for combin-
ing individual predictions from the ECG and SCG based on some selected cardiac features.
The ANN configuration and related rationales are discussed in Chapter 5.2.
Although features used in Chapter 5.3 were demonstrated to be fair representatives of
the cardiac signals and were effective in quiescence prediction, this pilot work of near real-
time implementation further scales down the features for the sake of computational and
time efficiency. In summary, the revised feature set contains a total number of 4 single-
value features, out of which 2 are from the ECG signal and 2 are from the SCG signal. The
procedure of selecting the features set is similar to that presented in Chapter 5.3. A detailed
description and analysis of the revised feature set are presented in Appendix B.
6.3.5 Training, Cross-Validation and Testing
To validate the real-time prediction, training and testing of the ANN were made on cardiac
data acquired from two cohorts of subjects. One cohort consists of five healthy subjects
(mean age: 26; age range: 24-30 ; female/male: 1/4), and the other cohort consists of three
cardiac patients (mean age: 61; age range: 41-71; female/male: 1/2). The testing was
conducted on two healthy subjects in a real-time scenario, while the rest of the subjects
were tested using their pre-recorded data in a simulated real-time manner.
Similar to the validation procedure in Chapter 5.4, training and testing were carried out
in a leave-one-out manner within the two cohorts. Testing for a designated subject involves
feeding the consecutive frames of the subject-specific data sequentially to the trained ANN.
The testing output, fused predictions, were compared against the baseline quiescence de-
rived from subject-specific echocardiography.
To train the ANN, the corresponding training dataset was constructed using the cardiac
data from the rest of the subjects who belong to the same cohort as the designated subject.
The training dataset contains categorized frames if data, labeled as “ECG” and “SCG”. The
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labeling was made by comparing the ECG- and SCG-based predictions with the quiescence
derived from the subject-specific echocardiography, respectively. Illustrations of signals
that were assigned to different categories are shown in Figure 6.7. The modality that led to
a smaller prediction error was considered as the optimal modality for a particular cardiac
cycle. Accordingly, the corresponding data frames that served for quiescence prediction
for the cardiac cycle was assigned the same modality as the cardiac cycle.
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Figure 6.7: Examples of situations when different categories were assigned by the ANN
binary classifier. The assignment was made according to the baseline subject-specific
echocardiography. (A): Intuitively, when both the ECG and SCG signals are normal and
devoid of noise, the SCG-based prediction will be assigned. (B) and (C): In the case when
the SCG signal is noisy, the ECG-based prediction is assigned.
Overall, each category consisted of half of the training dataset. The training dataset
was further randomly divided into four parts, one of which was used for cross-validation.
Within each part of the training dataset, the percentages of the two categories remain con-
sistent with the overall category percentages in the training dataset. On average, for each
individual, the number of frames used for training the ANN was 7101, corresponding to an
average of 720 cardiac cycle.
6.4 Results
6.4.1 Latency
As discussed in Section 6.2, two time constraints are imposed on the near real-time imple-
mentation, both of which are closely related to the latency introduced by the computerized
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processing, ∆t4. First, ∆t4 cannot exceed the time tolerance ∆T ∗ = 0.1 s. Second, the
total latency ∆T has to be small enough to guarantee an effective prediction for gating.
To estimate ∆t4 of processing a single data frame, the latency of individual computer-
ized processing module was first estimated. This was achieved by measuring the total time,
T , of an individual module spent in processing a consecutive n1 = 500 frames of 97 data
samples6. The estimated duration t to process a single frame of 97 data samples is t = T
n1
.
Table 6.2 summarizes the estimated duration introduced by modules in the computerized
processing. In a similar manner, the total duration of processing a frame of 97 data samples
was estimated.










In fact, the latency associated with each data frame varies because the amount of com-
puterized processing involved with each data frame differs. Frames with a new reference
detected requires extra operations for quiescence prediction, compared with the frames
without a reference, thereby introducing a longer latency. Essentially, this longer latency
due to the prediction operations primarily affects the prediction for gating. An estimation
of the computerized processing duration that includes quiescence prediction operations re-
ported an average of ∆t̄4 = 5.10 ms, leading to the total latency
∆T̄ecg = 15.51 ms + 5.10 ms = 20.61 ms, (6.6)
6An alternative approach is using the MATLAB Profiler.
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for the ECG, and for the SCG
∆T̄scg = 38.80 µs + 5.10 µs = 5.14 ms. (6.7)
Therefore, the first time constraint is satisfied, namely,
∆t̄4 = 5.10 ms < ∆T
∗. (6.8)
The second time constraint relates to the prediction for gating. Failure in providing an
effective prediction results in missing prospective gating for a cardiac cycle. The missing
count is reported in Table 6.4. Overall, the total latency associated with both signals were
rational for generating effective predictions for gating, namely,
∆Tg > max(∆T̄ecg,∆T̄scg) + 33.50 ms + ∆td = 54.11 ms + ∆td. (6.9)
Therefore, the near real-time implementation of the multimodal framework is feasible.
As a side note, prior to the real-time quiescence prediction, loading the DLL for com-
puterized processing took approximately 11 s and the pre-test for initialization took approx-
imately 0.1 s. It was also observed that the computational efficiency was enhanced if other
applications on the computer were terminated while the quiescence prediction program is
ongoing.
6.4.2 Artificial Neural Network Classification
The subjects’ clinical characteristics and corresponding ANN accuracy are presented in
Table 6.3, in order of increasing heart rate, within each cohort. Subjects H1 to H5 are from
the cohort of healthy subjects and P1 to P3 are from the cohort of cardiac patients. The
classification accuracy is the percentage of correct categories being identified. Among all
the subjects, the computerized processing were tested on H3 and H5 in a real-time scenario,
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while the rest of the subjects were tested using their pre-recorded data.
Table 6.3: Subject Clinical Characteristics and ANN Accuracy
Healthy Subjects
Subject HR (bpm) HRV (ms) Age (year)/Gender Weight (lbs) Height (in) Race Accuracy (%)
H1 53 28 27/F 100 62 White 98.5
H2 68 45 27/M 155 68 Asian 97.3
H3† 72 50 24/M 185 70 White 99.3
H4 75 50 26/M 120 65 Asian 99.1
H5† 76 32 25/M 190 72 White 98.8
Mean 69 41 26/- 150 67 - 98.6
Std 9.4 10.3 1.7/- 39.5 3.6 - 0.8
Cardiac Patients
P1 63 102 71/F 160 67 White 97.1
P2 73 57 41/M 265 74 Black 97.5
P3 80 60 70/M 170 69 White 98.0
Mean 72 73 61/- 198 70 - 97.5
Std 8.5 25.1 17.0/- 58.0 3.6 - 0.5
† Subjects H3 and H5 were bold to indicate that the computerized processing were tested on the in
a real-time scenario, while the rest of the subjects were tested using their pre-recorded data.
The average classification accuracy is 98.6% for the healthy cohort and 97.5% for the
patient cohort. Compared with the classification accuracy presented in Table 5.3 (89.9%
for healthy subjects and 80.6% for cardiac patients), the accuracy derived from the new
feature set has been improved, indicating that the revised feature set is more efficient in
distinguishing the ECG and SCG signals.
6.4.3 Quiescence Prediction
The prediction error, in milliseconds, was calculated as the absolute difference between the
predicted quiescence and the baseline subject-specific echocardiography. The prediction
errors of the ECG-, SCG- and fusion-based methods for each individual are shown in Figure
6.8. The overall prediction error associated with ECG-, SCG- and WF-based methods over
all subjects are 59.58±20.01 ms, 34.67±15.63 ms and 27.24±12.16 ms. The fusion-based
prediction demonstrated the least prediction error and is associated with less variation in
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Figure 6.8: Quiescence prediction error derived from difference quiescent prediction meth-
ods. The overall prediction error associated with ECG-, SCG- and WF-based method over
all subjects are 59.58 ms, 34.67 ms and 27.24 ms. The black dot in each boxplot indicates
the median value.
Table 6.4: Average Quiescence Prediction Error
Healthy Subjects
Subject MN/TN† Ēecg (ms) Ēscg (ms) Ēwf (ms)
H1 20/286 55.49 35.16 22.21
H2 12/305 57.14 27.52 17.56
H3 25/311 43.66 39.05 29.38
H4 19/275 48.07 28.07 22.47
H5 23/298 66.43 38.37 32.11
Mean 20/295 54.15 33.63 24.75
Std 5/15 19.56 15.05 11.86
Cardiac Patients
P1 20/286 58.02 41.28 30.04
P2 25/301 79.81 34.31 35.44
P3 27/300 68.03 33.59 28.73
Mean 24/296 68.62 36.40 31.40
Std 4/8 17.32 16.41 11.51
† MN: Number of missed cardiac cycles by the SCG-based pre-
diction; TN: Total number of cardiac cycles tested.
Table 6.4 reports the average prediction error for each individual as well as the missing
count for the SCG-based prediction. The missing count is the number of cardiac cycles that
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did not have predictions by the SCG-based prediction among the total number of cardiac
cycles. The missing scenario can be a result of not having enough time before the predicted
quiescence occurs, or inability to identify the heart sound associated waveforms in the SCG
signal. On average, the SCG-based method failed in predicting quiescence for 6.8% of the
cardiac cycles over all healthy subjects and 9.4% over the cardiac patients. In summary, the
fusion-based prediction was an effective method for improving the accuracy of quiescence
prediction.
6.5 Remarks
This work demonstrated that a near real-time ECG-SCG-based multimodal framework is
feasible and effective for cardiac quiescence prediction. The augmentation of the traditional
ECG-only-based prediction also seamlessly incorporated a pre-test and pre-categorization
to facilitate the real-time prediction prior to the CTA exam. The promising results rein-
forces a positive prospect of the multimodal gating to be applied to the clinical setting.
One limitation of this work comes from the wireless ECG transceiver which introduces
a latency of 15 ms. Replacing the wireless transceiver with a wired transceiver can sig-
nificantly reduce the total latency, thereby easing the gating from missing the predicted
timing.
The next limitation is lacking a thorough way of evaluating the goodness of the ECG
signal. While the relative goodness of the SCG can possibly be evaluated by the SCG
index reported in Chapter 5.6, it is helpful to develop methods for identifying the quality
of the ECG signal. The purpose is to exclude the unreliable prediction derived from the
sub-optimal ECG signal. An example of a sub-optimal ECG signal can be found in Figure
6.7 (C), where both the ECG and SCG signals are significantly distorted. In this case, the
ECG-based prediction becomes unreliable. However, because the ANN binary classifier
inclusively deals with two categories, ECG and SCG, the classification decision selects the
relatively less distorted category rather than rejecting both categories. Ideally, this cardiac
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cycle may be skipped for quiescence prediction.
Another limitation is the assumption that the adjacent data frames carry related cardiac
information. Specifically, a frame of 97 data samples that are partly from the diastolic
period of a cardiac cycle are used for predicting the systolic quiescence in the following
cardiac cycle. Similarly, diastolic quiescence prediction requires features extracted from
the data frame in the systolic period of the same cardiac cycle. Although intuitive, this
assumption has not been validated.
Future work can focus on developing an independent device dedicated to the near real-
time prediction rather than relying on a laptop. Appendix C outlines a schematic hardware
layout as a potential vision of the dedicated device.
Future work can also investigate changing the processing window size and offset, as
well as the sample rate to optimize the performance for quiescence prediction. Similarly,
to improve the computerized processing aspect, particularly to optimize the execution time
of a program, the algorithm, data structure, input, platform (operating system version or





This work demonstrated that the SCG-derived motion information can achieve improved
quiescence prediction accuracy and that the sub-optimal ECG-only-based prediction can
be augmented by an ECG-SCG dual-gating framework for marked improvement. Further-
more, this work reinforces the potential of the real-time dual-gating to be translated to clin-
ical applications through the proof-of-concept prototype effort. In addition, the promising
results with the SCG signal indicate that other cardiac sensing modalities, such as the blood
pressure and photoplethysmogram, can be exploited and potentially be used to enhance the
cardiac imaging process.
On a broader scope, this work lays the groundwork for demonstrating the reliability of
the cardiac CTA in achieving enhanced patient health outcomes for examining individu-
als with suspected CVDs. This work also contributes to accelerating CTA in becoming a
clinically accepted mainstream diagnostic tool for assessing coronary segments.
The continuing pursuit of better health care and the growing attention to CVDs motivate
this work on enhancing techniques to assess cardiac related health issues. The wide use of
the prospective cardiac CTA can significantly reduce the radiation dose which is crucial for
the health of many individuals. The methods and algorithms developed and discussed in
this work could significantly improve the assessment of CVD, and potentially advance the
understanding of cardiovascular disease with the development of a framework to achieve
better cardiac imaging.
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7.2 Limitations and Future Work
One critical assumption of this work is that the interventricular septal (IVS) motion derived
from patient-specific echocardiography serves as the baseline for coronary vessel motion.
Ultimately, to validate the fusion-based prediction, the quiescence derived from the fusion-
based method needs to correlate with the motion of coronary arteries derived from the CTA.
However, because of radiation dose, currently it is not possible to obtain the CTA data for a
large number of cardiac cycles. On the other hand, it has been shown that the motion of the
IVS is a very good marker of coronary arterial motion [36]. Therefore, echocardiography-
derived motion serves as an excellent, and ethically acceptable, surrogate marker of coro-
nary vessel motion. Looking ahead, a superior marker closer to coronary vessel motion
such as angiography could be explored in future work.
Another limitation is the small sample size in this work. As the subject population
enlarges and subject demographics widens, stronger conclusions on the performance of the
multimodal framework can be made.
In addition to these limitations, there is a lack of standardization for some issues in the
field of cardiac gating. Solving these issues will significantly accelerate related works, and
advance the development of a more intelligent imaging system that eases the radiologic
technologists (RTs) from additional operations.
1. The decision of whether to use a retrospective or prospective gating technique is
currently exclusively decided by the RTs. The decision is made based on the ob-
servation of heart rate and heart rate variability. As a rule of thumb, higher heart
rate (e.g. greater than 83 bpm) or variability prompts the use of retrospective gating,
and lower heart rate and variability prompts the use of prospective gating. However,
this is not reliable since abnormal heart rates may be missed by a manual screening
for a short period of time. Therefore, it is necessary to come up with a standard to
strategically, or even intelligently without human effort, to decide the suitable gating
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technique to use. This may include consideration of the individual’s physiological
condition such as symptoms, height and weight.
2. Data acquisition in systole or diastole for prospective gating is solely heart rate de-
pendent and varies with different ECG-gating functions. Chapter 2.1.1 introduced
several different ECG-gating functions that are used by different cardiac imaging
machines. To date, there is no universal ECG-gating function that can be used by all,
indicating that ECG-based prediction may be inconsistently used.
3. The annotation of the SCG signal is challenging as compared to ECG due to the
existence of large morphological variability of SCG among the subjects and its sus-
ceptibility to distortions from body motion, respiration and noise artifacts. An accu-
rate and robust approach to identify features of SCG signals is need to formulate a
universal annotation template for the SCG.
Future work can investigate the effect of different acceleration sensor locations, e.g.
sternum versus apex, to the waveforms of the heart sound associated components in the
SCG signal and to the timing of the SCG reference point within the cardiac cycle for qui-
escence prediction.
Furthermore, future research may evaluate the application of retrospective and prospec-
tive gating for cardiac CTA data acquisition, identify the clinical trend of cardiac gating
techniques, and investigate potential parameters that may have led to such a clinical trend
in order to promote solutions to the existing challenges in cardiac CTA. The significance of
this is to provide a historical review of the application of cardiac CTA in diagnosing CVDs,
but also to stress the significance of developing a more reliable prospective gating approach






Table A.1: Comparison of the accelerometers used in the Enhanced and Custom Systems
Enhanced Custom
Sensor Type 352A24/NC
(PCB PIEZOTRONICS, Depew, NY, USA)
ADXL327
(Analog Devices, Norwood, MA, USA)
Weight 0.8 g 5 g
Sensing Element Ceramic MEMS (Polysilicon)
Housing Material Aluminum MEMS (Polysilicon)
Bandwidth (tuned) 0.4-12 kHz 0-50 Hz
Spectral Noise† 4 µg/
√
Hz (10− 100 Hz)
15 µg/
√
Hz (1− 10 Hz)
80 µg/
√




Sensitivity 100 µV/g 420 µV/g
† g is the earth gravity constant and g = 9.8 m/s2.
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APPENDIX B
REVISED ANN FEATURE SET
This section describes the selection of a revised feature set for the real-time fusion-based
prediction. Compared with the features reported in Chapter 5, this revised feature set has
less number of features, and the extraction of features are less time-consumed. However,
the revised feature set demonstrated improved quiescence prediction accuracy based on the
results reported in Chapter 6.4.
The selection of features involves two stages. The first stage is to generate an original
feature set, from which a more select feature set is obtained in the second stage. The
original set of features to be extracted from a frame of data samples are:
1. ARecg: AR model coefficients of order 7 from the ECG signal. Previous work has
demonstrated the effectiveness of the AR(7) model in quantitatively delineating the
ECG waveforms [132]. This work empirically found that the first four coefficients
that correspond to the 5th − 7th data samples enabled achievement of high ANN
classification accuracy. Therefore, the last three normalized coefficients (AR5ecg(7)−
AR7ecg(7)) were used as features.
2. STFTscg: Short-time Fourier transform (STFT) of the SCG signal. The mean (STFT 1scg)
and variance (STFT 2scg) of the real part of the frequency spectrum were used as fea-
tures.
3. DWTscg: DWT coefficients from the SCG signal, decomposed down to level 6 using
“Coif5” as the mother wavelet1. The mean (DWT 1scg) and variance (DWT
2
scg) of
the coefficients were used as features. The DWT allows for obtaining the temporal
1To ensure that the wavelet coefficients are free from boundary effects, a good rule is to set the decompo-
sition level no greater than log2(L) for a signal of length L. In this work, the sample size of the processing
frame is 97.
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information of the signal in addition to the frequency information from the STFT.
In summary, the original feature set consists a total number of 7 single-value features.
Among the 7 features, 3 are from the ECG signal and 4 are from the SCG signal. Table B.1
provides a listing of the features and their corresponding numbers.
Table B.1: Original Features
ARecg STFTscg DWTscg Total
3 2 2 7
The selected features embody the capability in capturing the difference between the
two categories. A direct visualization of the 5th AR(7) coefficient, variance of the STFT
and mean of the DWT are presented by category in Figure B.1. The ranges of features are



















































Mean of DWT by Category
Figure B.1: Features by category. The features presented are (A) AR5ecg(7), (B) STFT
2
scg
and (C) DWT 1scg.
Each feature was normalized by subtracting the minimum and then divided by the max-
imum. In addition, principal component analysis (PCA) was applied where eigenvalues
less than 20% of the largest eigenvalue were discarded. The relative importance of the fea-
tures were than evaluated using the neighborhood component analysis (NCA) [111] with








































































Figure B.2: Relative feature weight evaluated by the NCA. Features in red bars demonstrate
less importance in distinguishing the two categories (ECG and SCG), and consequently
were discarded.
Therefore, a select feature set extracted from the original feature set was constructed.
The select feature set consists of 4 single-value features, 2 of which are from the ECG
signal and 2 are from the SCG signal. Table B.2 presents a listing of the select features and
their corresponding numbers.
Table B.2: Select Features
ARecg STFTscg DWTscg Total
2 1 1 4
The computational complexity is a concern for the real-time processing. The classic
Fourier transform-based spectral analysis is relatively computationally expensive (its com-
putational complexity is O(N2) for N samples) and time consuming for near real-time
processing. The STFT is an alternative technique to analyze short duration of data with a
faster computation. The computational complexity of STFT is O(N log2N) for N sam-
ples.
Compared with the Fourier-based transform, the wavelet transform has the advantage of
adaptively alternating the transforming window length in the face of frequency change in a
way that the window shortens in time and lengthens in frequency for high frequency signals
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to capture the high-frequency component in the transient behavior, vice versa for low-
frequency components. Many one dimensional DWT can be accomplished in O(N). Due
to the recursive nature of the AR algorithm, the computational cost of the AR parameter
estimation varies, depending on the size of the data samples involved.
With regard to the time consumption, the training of ANN is carried out beforehand
using cardiac data from subjects within the same cohort, so the ANN configuration param-
eters such as the weights of each layer, are pre-defined. In the real-time scenario, prediction
with the trained ANN is solely a process of vector multiplication and thresholding. Essen-
tially, the time consumption of extraction features primarily contributes to the total latency
of the computerized processing.
To evaluate the time consumption of the AR modelling, STFT, and DWT algorithms,
a sequence of 97 data sample underwent each algorithm individually for 1000 times, the
average processing time associated with each algorithm is summarized in Figure B.3. The
algorithm parameters were chosen in such a way that simulated the near real-time setting.
In the spectrogram that uses the STFT over 0-50 Hz frequency range, the segment length
to perform windowing was 64 data samples, and the overlapping was 60 data samples. The



















Figure B.3: Average processing duration associated with AR modelling, STFT, and DWT
for processing a frame of 97 samples. The red bars in each box indicates the median value.
The average processing durations associated with the primary algorithms for the fusion-
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based prediction (AR, STFT and DWT) were all fractions of a millisecond. A more com-
plete report of the computerized duration introduced by each module of the computerized




As a proof-of-principle, the near real-time implementation was demonstrated with a typical
laptop computer. However, to approach a direct interface with imaging equipment, an
independent device dedicated to the computerized processing for quiescence prediction is
envisioned. The rationales are as follows:
1. Dedicated processing: The independent device is designed for a dedicated purpose,
e.g., quiescence prediction, while the general-purpose computer is usually burdened
with multiple tasks such as managing running applications and background pro-
cesses. The additional tasks imposed to the general-purpose computer takes up extra
CPU efforts and memory allocation. Therefore, the dedicated device can achieve
higher performance for a specific task than a general-purpose computer.
2. Size reduction: The physical size of the dedicated device can be made much smaller,
and can be designed to be compatible with the clinical machines such as the working
station/computer of a designated CTA scanner.
3. Improvement in prediction accuracy: The selected DSP processor can possibly im-
prove the quiescent prediction accuracy. It is expected that more complicated al-
gorithms may be developed to refine the quiescent prediction, which will likely to
require higher floating point precision, faster clock speed and less data overhead.
4. Communication delay reduction: The communication between the hardware and
software platforms are currently controlled by the BHAPI whose routines such as
data transfer protocols, are encapsulated and cannot be changed easily for some par-
ticular requirements of this work. The communication delay can be significantly
reduced with a hands-on device.
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Figure C.1: Schematic layout of an independent device dedicated to the computerized pro-
cessing for quiescence prediction.
A schematic layout of an independent application-specific device is presented in Figure
C.1. The device consists of two modules, one for analog data acquisition, and another for
digital processing.
The analog data acquisition module acquires analog cardiac signals and relays amplified
analog signals to the digital processing module. A good data acquisition module minimizes
the latency in communication and improves prediction accuracy by acquiring signals with
high signal-to-noise ratio. The analog processing module for the ECG can be made by using
a standard ECG analog front end design [133], or using the off-the-shelf fully integrated
TI ADS1298 (TI, Dallas, TX, USA) circuit board [134]. Both of the ECG acquisition
options can be developed into wired communication. For the SCG signal, the Piezotronics
signal conditioner (PCB Piezotronics Inc., Depew, NY, USA) used in the enhanced data
acquisition system can remain be used for the SCG analog module as it effectively amplifies
the SCG signal.
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The digital processing module can potentially use the floating-point TMS320C6713
(C6713, TI, Dallas, TX, USA) as the DSP processor, in combination with the code com-
poser studio (CCS) as the integrated development environment for developing applications.
The selected processor and CCS are designed for dedicated processing, and the DSP chip
is adequately small to be re-framed for compatibility. The CCS supports low-level pro-
gramming language such as C. In addition, the selected DSP processor is a classic model
that has been widely applied to various research such as speech and acoustic recognition
system [135, 136]. Furthermore, the C6713 is very well suited for numerically intensive
algorithms due to the Very-Long Instruction Word (VLIW) architecture. The floating-point
feature can improve the prediction precision. Other features of the C6713 include 264 kB
of internal memory, eight functional or execution units composed of six arithmetic-logic
units (ALUs) and two multiplier units, and a 32-bit address bus to address 4 GB.
This work requires that the DSP processor to be able to achieve analog to digital conver-
sion for the analog input signals and pre-process the buffered samples by filtering out noise
and removing the baseline drift. In addition, quiescent predictions requires basic arithmetic
operations and DSP operations such as STFT, AR and DWT. Auxiliary components in the
digital processing module may include indicators for power status and gating mode status.
The output of the digital processing module is a trigger indicating the data acquisition of
the cardiac CTA. As a side note, the selected components for constructing the dedicated
device are easy to use, flexible, and economical.
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